CN1222318C - Cellulosic particle for pharmaceutical preparation - Google Patents
Cellulosic particle for pharmaceutical preparation Download PDFInfo
- Publication number
- CN1222318C CN1222318C CNB018184219A CN01818421A CN1222318C CN 1222318 C CN1222318 C CN 1222318C CN B018184219 A CNB018184219 A CN B018184219A CN 01818421 A CN01818421 A CN 01818421A CN 1222318 C CN1222318 C CN 1222318C
- Authority
- CN
- China
- Prior art keywords
- particles
- cellulose
- dispersion
- particle
- mesh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B16/00—Regeneration of cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2301/00—Characterised by the use of cellulose, modified cellulose or cellulose derivatives
- C08J2301/02—Cellulose; Modified cellulose
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及制剂用的纤维素粒子、该粒子的制备方法、其使用方法以及用这些纤维素粒子所制造出的包含活性成分的颗粒。The present invention relates to cellulose particles for formulations, methods for their preparation, methods for their use and active ingredient-containing granules produced from these cellulose particles.
背景技术Background technique
在制备包含有效组分的颗粒时可以使用各种方法。近年来,已经提出了一种包括将活性成分成层于粒子上的方法。特别是因为制药机得到了改进,所以使得将大量活性成分成层于相对较小的粒子上成为可能。结果,提出了各种使活性成分成层的方法。Various methods can be used in preparing the granules comprising the active ingredient. In recent years, a method involving layering active ingredients on particles has been proposed. Especially since improvements in pharmaceutical machinery have made it possible to layer large quantities of active ingredients onto relatively small particles. As a result, various methods of layering the active ingredient have been proposed.
例如,JP-A 61-1614公开了一种包括将活性成分成层于糖类核粒子上的方法;JP-A 7-173050和JP-A 4-283520公开了包括将活性成分成层于球形核上的方法,并且JP-A 2000-109426公开了一种包括将活性成分成层于微晶纤维素上的方法。For example, JP-A 61-1614 discloses a method comprising layering active ingredients on carbohydrate core particles; JP-A 7-173050 and JP-A 4-283520 disclose methods involving layering active ingredients on spherical A method on a core, and JP-A 2000-109426 discloses a method comprising layering an active ingredient on microcrystalline cellulose.
但是,在JP-A 61-1614中所公开的糖类核粒子具有一些如下的问题:However, the sugar core particle disclosed in JP-A 61-1614 has some problems as follows:
(1)难以制备具有适于活性组分成层的小粒径的核粒子,(1) It is difficult to prepare core particles having a small particle size suitable for active component layering,
(2)当用所述的糖类核粒子和水性的活性成分悬浮液来进行活性组分的成层时,作为核粒子的主要组分的糖自身溶解而使得表面变粘,从而使得该核粒子自身易于发生聚集,和(2) When the layering of the active ingredient is carried out with the saccharide core particle and the aqueous active ingredient suspension, the sugar which is the main component of the core particle dissolves itself to make the surface sticky, thereby making the core particle The particles themselves tend to aggregate, and
(3)该核粒子强度弱,并且在流化过程中容易磨损,同时又易于发生核粒子本身的聚集以及核粒子附着到包衣机壁上的现象,因此,收率变差。(3) The strength of the core particles is weak, and it is easy to wear during the fluidization process, and at the same time, the aggregation of the core particles itself and the phenomenon that the core particles are attached to the wall of the coating machine are easy to occur, so the yield becomes poor.
此外,在JP-A 7-173050或JP-A 4-283520所公开的球形核被用作核的情况中,该类球形核也具有一些如下的问题:Furthermore, in the case where the spherical core disclosed in JP-A 7-173050 or JP-A 4-283520 is used as the core, this type of spherical core also has some problems as follows:
(1)虽然由于球形核具有抗磨损的能力而几乎不被磨损并且具有优良的流动性,但是为了确保活性成分成层所需的流动性,必需增加气流供给量,并且由于流化过程中的气流量或者核因自身重量而导致的核间的碰撞,使成层的活性成分易于剥落,(1) Although the spherical core is hardly worn due to its anti-wear ability and has excellent fluidity, in order to ensure the fluidity required for active ingredient layering, it is necessary to increase the air supply rate, and due to the fluidization process The air flow or the collision between the cores caused by their own weight makes the layered active ingredients easy to peel off,
(2)虽然球形核具有优良的水吸收性,但是在成层的早期,当水性的活性成分悬浮液的喷雾速度增加时,因为其表面平整,所以易于发生聚集,和(2) Although the spherical core has excellent water absorption, aggregation tends to occur in the early stage of layering when the spray speed of the aqueous active ingredient suspension is increased because its surface is flat, and
(3)在用于制备口内快速溶解的片剂时,因为该球形核的强度太大,所以当给药时舌头会感到粗糙。(3) When used in the preparation of a rapidly dissolving tablet in the mouth, since the strength of the spherical core is too large, the tongue feels rough when administered.
此外,在如JP-A 2000-109426所公开的用微晶纤维素作为核时,仍然存在不易将活性成分成层的问题,这是因为In addition, when microcrystalline cellulose is used as the core as disclosed in JP-A 2000-109426, there is still the problem that the active ingredient is not easily layered, because
(1)该粒子具有低的敲击堆密度(tapped bulk density),因此当以适于活性成分成层的流速供给气流时,其可附着在包衣机上部的任何袋式过滤器上,(1) The particles have a low tapped bulk density so that they can attach to any bag filter in the upper part of the coating machine when supplied with an airflow at a flow rate suitable for layering of the active ingredient,
(2)其具有较大的休止角,因此其在包衣机中的流动性变差,和(2) It has a large angle of repose, so its fluidity in the coating machine becomes poor, and
(3)其在易于被磨损,因此不能获得粒度分布窄的颗粒。(3) It is easily attrited, so particles with a narrow particle size distribution cannot be obtained.
本发明的公开Disclosure of the invention
本发明鉴于这些现状,对药学领域中所用粒子的性质进行了广泛的研究,从而完成了本发明。In view of these present circumstances, the present invention has been accomplished through extensive studies on the properties of particles used in the field of pharmacy.
即,本发明提供That is, the present invention provides
(1)制剂用纤维素粒子,其包含不少于10%的具有60至350的平均聚合度的微晶纤维素,并且其具有0.60至0.95g/ml的敲击堆密度,其长宽比不低于0.7,形状系数为1.10至1.50,并且其平均粒径为10至400μm;(1) Cellulose particles for formulations comprising not less than 10% of microcrystalline cellulose having an average degree of polymerization of 60 to 350, and which have a tapped bulk density of 0.60 to 0.95 g/ml, an aspect ratio of Not less than 0.7, a shape factor of 1.10 to 1.50, and an average particle size of 10 to 400 μm;
(2)制造如上面(1)所述的制剂用纤维素粒子的方法,该方法包括下列步骤:将纤维素物质水解而获得60至350的平均聚合度,然后对这样水解的产物进行机械研磨而获得不高于15μm的平均粒径;制备包含所得微晶纤维素的分散液;将所述的分散液形成液滴;然后干燥所述的液滴;和(2) A method of producing cellulose particles for preparations as described in (1) above, the method comprising the steps of: hydrolyzing a cellulose substance to obtain an average degree of polymerization of 60 to 350, and then mechanically grinding the thus hydrolyzed product and obtaining an average particle diameter of not higher than 15 μm; preparing a dispersion comprising the obtained microcrystalline cellulose; forming said dispersion into droplets; then drying said droplets; and
(3)球形颗粒,其特征在于在如上面(1)所述的制剂用粒子的表面或内部包含药物。(3) Spherical particles characterized in that a drug is contained on the surface or inside of the particle for formulation as described in (1) above.
实施本发明的最佳方式Best Mode for Carrying Out the Invention
本发明的制剂用纤维素粒子包含不少于10%量的具有60至350的平均聚合度的微晶纤维素(在下文中简称为微晶纤维素)。当该微晶纤维素的含量不低于10%时,该粒子可具有适当的强度,并且可以减少在活性成分成层过程中由于摩擦而导致的损耗。从粒子强度和抗摩擦的观点来看,优选该制剂用纤维素粒子包含不少于30%量的微晶纤维素,优选不少于50%,并且更优选不少于70%。从药物制剂简化的观点来看,最优选100%的微晶纤维素。不建议微晶纤维素的含量低于10%,这是因为如果低于10%时会使得粒子强度低,并且由于摩擦而造成的损耗很大。The cellulose particles for formulations of the present invention contain microcrystalline cellulose having an average degree of polymerization of 60 to 350 (hereinafter simply referred to as microcrystalline cellulose) in an amount of not less than 10%. When the content of the microcrystalline cellulose is not less than 10%, the particles can have appropriate strength, and can reduce loss due to friction during active ingredient layering. From the viewpoint of particle strength and friction resistance, it is preferable that the cellulose particles for formulation contain microcrystalline cellulose in an amount of not less than 30%, preferably not less than 50%, and more preferably not less than 70%. From the viewpoint of simplification of the pharmaceutical preparation, 100% microcrystalline cellulose is most preferred. A microcrystalline cellulose content lower than 10% is not recommended because the particle strength will be low if it is lower than 10%, and the loss due to friction is large.
所用的微晶纤维素具有60至350的平均聚合度。其可以通过将纤维素物质如棉短绒、纸浆或再生纤维水解来获得,其中所述的水解为如酸解、碱解、蒸汽喷发分解或其中两种或三种方式的结合。或者在进行上述化学处理之前或之后可以进行机械处理如粉碎。The microcrystalline cellulose used has an average degree of polymerization of 60 to 350. It can be obtained by hydrolyzing cellulosic materials such as linters, pulp or regenerated fibers, such as acid hydrolysis, alkali hydrolysis, steam explosion decomposition or a combination of two or three of these methods. Alternatively, mechanical treatment such as pulverization may be performed before or after the above-mentioned chemical treatment.
不建议平均聚合度超过350,这是因为观察到纤维性状,因此难于对该微晶纤维素进行研磨,此外长宽比下降。不建议平均聚合度低于60,这是因为纤维素分子的缠结度降低,从而使得制剂用纤维素粒子的硬度不足。优选的平均聚合度为100至270,更优选120至200。An average degree of polymerization of more than 350 is not recommended because of the observation of fibrous properties, making it difficult to grind the microcrystalline cellulose, and furthermore, the aspect ratio decreases. It is not recommended that the average degree of polymerization be lower than 60 because the degree of entanglement of cellulose molecules decreases, thereby making the hardness of the cellulose particles for formulation insufficient. The preferred average degree of polymerization is 100 to 270, more preferably 120 to 200.
在粒子中,还可以加入微晶纤维素以外的其它成分。其实例有粘合剂(例如羟丙基纤维素、羟丙基甲基纤维素、聚乙烯醇、聚乙烯基吡咯烷酮、聚乙二醇等)、薄膜包衣剂(例如苯二甲酸羟丙基甲基纤维素、醋酸琥珀酸羟丙基甲基纤维素、羧甲基乙基纤维素、乙基纤维素、乙基纤维素水分散液、甲基丙烯酸氨基烷基酯共聚物E、甲基丙烯酸共聚物L、甲基丙烯酸共聚物S、甲基丙烯酸共聚物LD、甲基丙烯酸氨基烷基酯共聚物RS、硬化油等等)、表面活性剂(例如蔗糖脂肪酸酯、聚氧乙烯聚氧丙烯二醇、聚山梨醇酯、十二烷基硫酸钠等)、赋形剂(例如玉米淀粉、马铃薯淀粉、稻米淀粉、粉糖、乳糖、D-甘露醇、海藻糖、微晶纤维素和羧甲基纤维素钠等)、崩解剂(例如低置换度羟丙基纤维素、羧甲基纤维素钙、交联羧甲基纤维素钠、预胶化淀粉等)、无机物质(例如滑石、硬脂酸镁、轻质硅酸酐、合成硅酸铝、氧化钛等)、以及其它制剂上常用的添加剂。Components other than microcrystalline cellulose may also be added to the particles. Examples thereof are binders (such as hydroxypropylcellulose, hydroxypropylmethylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, etc.), film coating agents (such as hydroxypropyl phthalate Methyl cellulose, hydroxypropyl methyl cellulose acetate succinate, carboxymethyl ethyl cellulose, ethyl cellulose, ethyl cellulose aqueous dispersion, aminoalkyl methacrylate copolymer E, methyl Acrylic acid copolymer L, methacrylic acid copolymer S, methacrylic acid copolymer LD, aminoalkyl methacrylate copolymer RS, hardened oil, etc.), surfactants (such as sucrose fatty acid ester, polyoxyethylene poly Oxypropylene glycol, polysorbate, sodium lauryl sulfate, etc.), excipients (such as corn starch, potato starch, rice starch, powdered sugar, lactose, D-mannitol, trehalose, microcrystalline cellulose and sodium carboxymethylcellulose, etc.), disintegrants (such as low-substituted hydroxypropyl cellulose, calcium carboxymethylcellulose, croscarmellose sodium, pregelatinized starch, etc.), inorganic substances ( Such as talc, magnesium stearate, light silicic anhydride, synthetic aluminum silicate, titanium oxide, etc.), and other commonly used additives in preparations.
本发明的制剂用纤维素粒子具有0.60至0.95g/ml的敲击堆密度。不建议该敲击堆密度低于0.60g/ml,这是因为这样的粒子重量太轻,以至于必需降低将这样的粒子投入成层机中时的量。此外,不建议使用该密度的原因还在于在适用于活性成分成层的风量条件下该粒子会附着到安装在包衣机上部的任何袋滤器上,从而使得收率下降。另外,不建议敲击堆密度超过0.95g/ml,这是因为这样的粒子重量太大,以至于必需大大增加适于活性成分成层的粒子流化作用所需的风量。结果,由于高风量而使得活性成分易于剥落,从而使得活性成分的成层发生波动。优选的敲击堆密度为0.60至0.90g/ml。更优选为0.60至0.85g/ml,并且特别优选0.65-0.85g/ml。The cellulose particles for formulation of the present invention have a tapped bulk density of 0.60 to 0.95 g/ml. A tapped bulk density below 0.60 g/ml is not recommended because such particles are so light that it is necessary to reduce the amount of such particles that are fed into the layerer. In addition, this density is not recommended because at air volume conditions suitable for active ingredient layering, the particles will adhere to any bag filter installed in the upper part of the coater, resulting in a decrease in yield. In addition, tapping bulk densities in excess of 0.95 g/ml are not recommended because such particles are so heavy that it is necessary to greatly increase the air volume required for particle fluidization suitable for active ingredient layering. As a result, the active ingredient is easily peeled off due to the high air volume, so that the layering of the active ingredient fluctuates. A preferred tapped bulk density is from 0.60 to 0.90 g/ml. More preferably 0.60 to 0.85 g/ml, and particularly preferably 0.65-0.85 g/ml.
本发明的制剂用纤维素粒子具有不低于0.70的长宽比。当长宽比低于0.7时,活性成分成层后颗粒的长宽比变差,从产品美观的角度来看这是不希望出现的。优选长宽比不低于0.75,更优选不低于0.80。The cellulose particles for formulations of the present invention have an aspect ratio of not less than 0.70. When the aspect ratio is less than 0.7, the aspect ratio of the particles after the active ingredient is layered becomes poor, which is not desirable from the viewpoint of product aesthetics. Preferably the aspect ratio is not lower than 0.75, more preferably not lower than 0.80.
在本发明中,该制剂用纤维素粒子具有1.10至1.50的形状系数。不建议形状系数低于1.10,这是因为各粒子的表面是光滑的,从而使得水性的活性成分悬浮液或粘合剂溶液不易附着。不建议增加喷雾速度,这是因为这样做会在成层的过程中易于发生聚集。另一方面,不建议形状系数高于1.50,这是因为这种粒子的表面凸凹过多,以至于活性成分成层后的颗粒的凸凹多,从而使得颗粒的美观程度下降。此外,不建议形状系数高于1.50的原因还在于这种粒子在受到摩擦时易于磨损,从而易于造成粒子的聚集,并且因此而使得颗粒的粒度分布宽。此外,因为难于控制活性成分的释放速率,所以不建议对有大量凸凹的颗粒进行包衣。优选的形状系数为1.15至1.50,更优选1.15至1.45。In the present invention, the cellulose particles for formulations have a shape factor of 1.10 to 1.50. A shape factor below 1.10 is not recommended because the surface of each particle is smooth, making it difficult for aqueous active ingredient suspensions or binder solutions to adhere. Increasing the spray rate is not recommended as it tends to aggregate during layering. On the other hand, a shape factor higher than 1.50 is not recommended because the surface of such particles has too many bumps, so that the active ingredient layered particles have more bumps and bumps, which reduces the aesthetics of the particles. Furthermore, the reason why a shape factor higher than 1.50 is not recommended is also that such particles are prone to wear when subjected to friction, which tends to cause particle aggregation and thus wide particle size distribution. In addition, coating granules with a large number of concavities and concavities is not recommended because it is difficult to control the release rate of the active ingredient. A preferred shape factor is 1.15 to 1.50, more preferably 1.15 to 1.45.
在本发明中,该制剂用纤维素粒子具有10至400μm的平均粒径。因为难子进行活性成分的成层并且粒子本身易于发生聚集,所以不建议平均粒径低于10μm。此外,也不建议平均粒径高于400μm,这是因为这样会制造出粒径大的成层颗粒,其可能使舌头感到粗糙,因此使得服用性变差。此外,这样的大粒径在用于制备包含颗粒的片剂时会使得含量产生波动。此外,不建议的原因还在于在需要使用小粒径颗粒时所被成层的活性成分的数量会受到限制。该平均粒径优选40至400μm,更优选50至400μm,更进一步优选50至300μm,特别优选50至200μm。In the present invention, the cellulose particles for formulations have an average particle diameter of 10 to 400 μm. Average particle sizes below 10 μm are not recommended because of the difficulty in layering of the active ingredient and the tendency of the particles themselves to agglomerate. In addition, an average particle size higher than 400 μm is also not recommended because it produces layered particles with a large particle size, which may give a rough feeling to the tongue, thus deteriorating the dosability. Furthermore, such a large particle size can lead to content fluctuations when used in the preparation of tablets comprising granules. In addition, it is not recommended because the amount of active ingredient that can be layered is limited when it is necessary to use small particle size particles. The average particle diameter is preferably 40 to 400 μm, more preferably 50 to 400 μm, still more preferably 50 to 300 μm, particularly preferably 50 to 200 μm.
优选地,本发明的制剂用纤维素粒子具有0.15至0.60m2/g的比表面积。不优选低于0.15m2/g的比表面积,因为此时粒子表面变得平滑,使得水性的活性成分悬浮液或粘合剂溶液难于附着到其上。因为在成层过程中易于发生聚集,所以不优选增加喷雾速率。因为粒子受到摩擦易于被磨损,从而造成粒子的聚集,因此而将制备出具有宽的、不均匀的粒度分布的颗粒,所以不优选高于0.60m2/g的比表面积。Preferably, the cellulose particles for formulations of the present invention have a specific surface area of 0.15 to 0.60 m 2 /g. A specific surface area of less than 0.15 m 2 /g is not preferred because then the particle surface becomes smooth, making it difficult for an aqueous active ingredient suspension or binder solution to adhere thereto. Increasing the spray rate is not preferred because aggregation tends to occur during layering. Specific surface areas higher than 0.60 m 2 /g are not preferred because particles are subject to friction and tend to be attrited, thereby causing particle aggregation and thus producing particles with a broad, non-uniform particle size distribution.
优选地,本发明的制剂用纤维素粒子具有不低于1.50%的水汽吸附量。优选该水汽吸附量不低于1.50%,这是因为如果吸水性不足,当活性成分的悬浮液被喷雾或当用水性粘合剂溶液来进行活性成分的成层时,可能会导致粒子聚集并且其将被附着到包衣机的壁上。Preferably, the cellulose particles for formulations of the present invention have a moisture adsorption capacity of not less than 1.50%. It is preferable that the moisture absorption amount is not lower than 1.50%, because if the water absorption is insufficient, when the suspension of the active ingredient is sprayed or when the layering of the active ingredient is performed with an aqueous binder solution, aggregation of particles may be caused and It will be attached to the wall of the coater.
优选地,本发明的制剂用纤维素粒子具有130至630mN的负荷峰值。不优选低于130mN的负荷峰值是因为这种粒子的强度不足,因此在成层的过程中粒子由于摩擦或撞击而易于磨损,从而造成粒子的聚集,因此制造的颗粒具有宽的和不均匀的粒度分布。不优选高于630mN的负荷峰值是因为这种粒子的强度太大,从而当给药时会使得舌头感觉粗糙。Preferably, the cellulose particles for formulation of the present invention have a peak load of 130 to 630 mN. The load peak value lower than 130mN is not preferred because the strength of such particles is insufficient, so the particles are easily worn due to friction or impact during the layering process, resulting in aggregation of particles, so the manufactured particles have wide and uneven Particle size distribution. Load peaks above 630 mN are not preferred because the strength of such particles is too great, causing a rough feeling on the tongue when administered.
优选地,本发明的制剂用纤维素粒子具有不高于41°的休止角。不优选超过41°的休止角是因为这种粒子的流动性差,从而使得在活性成分的成层过程中发生粒子的聚集。更优选地,休止角不高于39°,并且更加优选地不高于37°。Preferably, the cellulose particles for formulation of the present invention have an angle of repose not higher than 41°. An angle of repose exceeding 41° is not preferred because such particles have poor fluidity, so that aggregation of the particles occurs during the layering of the active ingredient. More preferably, the angle of repose is not higher than 39°, and even more preferably not higher than 37°.
希望该制剂用的纤维素粒子的脆性低。不希望其脆性高是因为脆性高的粒子受到摩擦时易于磨损,从而造成粒子的聚集,因此制造出的颗粒具有宽并且不均匀的粒度分布。It is desirable that the cellulose particles used in the preparation have low brittleness. High brittleness is undesirable because particles with high brittleness are prone to wear when subjected to friction, resulting in aggregation of particles, thus producing particles with a broad and non-uniform particle size distribution.
制造本发明的制剂用纤维素粒子的方法应该包括如下所述的湿式研磨步骤和喷雾干燥步骤。当使用包含这两个步骤的方法时,可得到具有这里所定义的物理性质的制剂用纤维素粒子。否则很难获得本发明的制剂用纤维素粒子,特别是很难获得同时满足具有相对小的平均粒径和大的形状系数要求的纤维素粒子。The method for producing the cellulose particles for formulation of the present invention should include a wet milling step and a spray drying step as described below. When using a method comprising these two steps, formulation cellulose particles having the physical properties defined herein can be obtained. Otherwise, it is difficult to obtain the cellulose particles for formulation of the present invention, especially to obtain cellulose particles satisfying the requirements of having a relatively small average particle diameter and a large shape coefficient at the same time.
例如,本发明的制剂用纤维素粒子可以用下面的方法来制造。For example, the cellulose particles for pharmaceutical preparations of the present invention can be produced by the following method.
首先,将纤维素物质如棉短绒、纸浆和再生纤维进行水解,如酸解、碱解、蒸汽喷发分解或其中两种或三种方式的结合,从而获得60至350的聚合度。在进行水解前,可以实施如下所述的机械处理。通过对所得水解混合物过滤、洗涤或倾析而获得的纤维素本身的分散液优选具有不高于300μS/cm的电导率。不优选超过300μS/cm的电导率,这是因为在水解时产生的杂质会污染该制剂用的纤维素粒子。将该分散液进行纯化以获得优选不高于150μS/cm的电导率,并且特别优选地该电导率不高于75μS/cm,从而可以获得饼状(cake-like)的产物,然后用其进行随后的湿式研磨步骤。First, cellulosic materials such as linters, pulp, and regenerated fibers are subjected to hydrolysis, such as acid hydrolysis, alkali hydrolysis, steam explosion decomposition, or a combination of two or three of these, to obtain a degree of polymerization of 60 to 350. Before carrying out the hydrolysis, mechanical treatment as described below may be carried out. The dispersion of cellulose itself obtained by filtering, washing or decanting the resulting hydrolyzed mixture preferably has an electrical conductivity of not higher than 300 μS/cm. A conductivity exceeding 300 [mu]S/cm is not preferred because impurities generated upon hydrolysis contaminate the cellulose particles used in the formulation. The dispersion is purified to obtain a conductivity preferably not higher than 150 μS/cm, and particularly preferably not higher than 75 μS/cm, so that a cake-like product can be obtained, which is then used for Subsequent wet grinding step.
在湿式研磨步骤中,通过例如研磨处理来对上面所得的饼状产品进行机械处理。或者可将其转化成包含该饼状产物的分散液,然后通过例如研磨处理来对其进行机械处理。或者,可通过其组合来对其进行处理。由此,在该纤维素分散液中的微晶纤维素的粒径不高于15μm。不建议该粒径超过15μm,这是因为如果粒径超过15μm的话,会使得该制剂用纤维素粒子的敲击堆密度变低,同时粒子强度下降。该粒径优选不超过13μm,更优选不超过10μm。In the wet milling step, the cake-like product obtained above is mechanically treated, for example by milling. Alternatively it can be converted into a dispersion comprising the cake-like product, which is then treated mechanically, eg by grinding. Alternatively, they can be processed by their combination. Thus, the particle diameter of microcrystalline cellulose in the cellulose dispersion is not higher than 15 μm. It is not recommended that the particle size exceed 15 μm, because if the particle size exceeds 15 μm, the tapping bulk density of the cellulose particles for the formulation will become low, and the particle strength will decrease at the same time. The particle size is preferably not more than 13 μm, more preferably not more than 10 μm.
当通过倾析法等进行纯化时,可以纤维素分散液直接进行机械处理。When purification is performed by decantation or the like, the cellulose dispersion may be mechanically treated as it is.
或者,通过将纤维素分散液进行干燥而获得的微晶纤维素粉末可进行如上所述的粉碎或研磨处理,然后与水混合,从而获得所需的粒径。或者可以将该粉末与水混合而得到悬浮液,然后将该悬浮液进行如上所述的研磨处理,从而获得所需的粒径。或者,该粉末可以用上述方法的组合来进行处理。此外,通过将微晶纤维素进行粉碎或研磨所获得的粉末一旦干燥,就可以与在水解后已经通过湿式研磨调整了粒径的微晶纤维素进行混合,从而获得纤维素分散液。Alternatively, the microcrystalline cellulose powder obtained by drying the cellulose dispersion may be pulverized or ground as described above, and then mixed with water to obtain a desired particle size. Alternatively the powder can be mixed with water to obtain a suspension which is then subjected to milling as described above to obtain the desired particle size. Alternatively, the powder can be treated with a combination of the above methods. Furthermore, once dried, powder obtained by pulverizing or grinding microcrystalline cellulose may be mixed with microcrystalline cellulose whose particle size has been adjusted by wet grinding after hydrolysis to obtain a cellulose dispersion.
该机械处理可以通过常规的方法来进行。一种实施方案如下。当对该饼状产物进行处理时,可以使用混合搅拌机(例如,万能混合搅拌机等)或混练研磨机(例如,乳钵、捏合机等),在例如25至80%,优选30至60%的固体含量下进行粉碎。当对分散液进行处理时,可以使用混合分散机(例如均化机、高压均化机等)或介质研磨机(例如湿式振动研磨机、湿式行星式振动研磨机、湿式球磨机、湿式涂料振动器等),在1至30%的固体含量下进行粉碎。This mechanical treatment can be performed by a conventional method. One embodiment is as follows. When the cake-like product is processed, a mixing mixer (for example, a universal mixing mixer, etc.) or a kneading and grinding machine (for example, a mortar, a kneader, etc.) can be used, for example, at 25 to 80%, preferably 30 to 60%. The solid content is crushed. When the dispersion is processed, a mixing and dispersing machine (such as a homogenizer, a high-pressure homogenizer, etc.) or a media mill (such as a wet vibrating mill, a wet planetary vibrating mill, a wet ball mill, a wet paint vibrator) can be used etc.), pulverization is carried out at a solid content of 1 to 30%.
将所得的经研磨的饼状产物和包含经研磨的纤维素的分散液稀释至约1至25%的浓度,从而获得纤维素自身的分散液,其粒径易于控制到在如下所述的干燥步骤中所需的粒径。将该纤维素自身的分散液的pH值调至5至8.5。The resulting milled cake-like product and the dispersion comprising milled cellulose are diluted to a concentration of about 1 to 25%, thereby obtaining a dispersion of cellulose itself, the particle size of which can be easily controlled in a drying process as described below. The desired particle size in the step. The pH of the dispersion of the cellulose itself is adjusted to 5 to 8.5.
当含有微晶纤维素以外的其它成分时,可以在水解后将所述的活性成分与该饼状产物进行混合,或者可以将所述的活性成分与用上述方法所得的纤维素分散液进行混合。When other components other than microcrystalline cellulose are contained, the active component may be mixed with the cake product after hydrolysis, or the active component may be mixed with the cellulose dispersion obtained by the above method .
随后,将前述的纤维素分散液转变成液滴,然后通过喷雾干燥来对其进行干燥,其中所述的喷雾干燥可使用旋转盘、双流成对喷嘴、压力喷嘴等。Subsequently, the aforementioned cellulose dispersion liquid is converted into liquid droplets, which are then dried by spray drying using a rotating disc, double-flow paired nozzles, pressure nozzles, and the like.
用于喷雾干燥的机械和喷雾干燥的方法不受限制。但是,从赋予本发明制剂用纤维素粒子的特性的角度而言,建议使用旋转盘的喷雾干燥法。在用旋转盘来进行喷雾干燥法的过程中,液体进料的速度、液体的固体含量、旋转盘的直径、旋转盘的速度和干燥温度并没有特别的限制。一个实施方案如下。将固体含量大于或等于l%的包含微晶纤维素的分散液供给到直径为3至50cm的旋转盘上,该旋转盘以500至30000rpm的速度动转,同时控制该液体的进料速度和干燥温度,从而获得所需的粒径。The machinery used for spray drying and the method of spray drying are not limited. However, from the viewpoint of imparting properties to the cellulose particles for formulations of the present invention, a spray-drying method using a rotating disk is recommended. In the spray drying process using a rotating disk, the liquid feed rate, the solid content of the liquid, the diameter of the rotating disk, the speed of the rotating disk and the drying temperature are not particularly limited. One embodiment is as follows. The dispersion liquid containing microcrystalline cellulose having a solid content greater than or equal to 1% is supplied to a rotating disk with a diameter of 3 to 50 cm, and the rotating disk is rotated at a speed of 500 to 30000 rpm while controlling the feed rate of the liquid and drying temperature to obtain the desired particle size.
用于进行喷雾干燥的微晶纤维素分散液中的固体含量优选为1至25%。优选固体含量等于或高于1%,这是因为如果粒子的聚集不足,则难以获得具有所需粒径的微晶纤维素粒子。并且从干燥效率的角度来看,其也是优选的。另一方面,不优选超过25%的固体含量,这是因为固体含量超过25%时,该纤维素分散液的粘度增加,因此在干燥后易于产生粗大的粒子。该固体含量更优选为3至20%,最优选为5至20%。The solids content in the microcrystalline cellulose dispersion for spray drying is preferably 1 to 25%. The solid content is preferably equal to or higher than 1%, because it is difficult to obtain microcrystalline cellulose particles having a desired particle size if aggregation of the particles is insufficient. And it is also preferable from the standpoint of drying efficiency. On the other hand, a solid content exceeding 25% is not preferable because the viscosity of the cellulose dispersion increases when the solid content exceeds 25%, and thus coarse particles tend to be generated after drying. The solids content is more preferably 3 to 20%, most preferably 5 to 20%.
干燥后的制剂用纤维素粒子的干燥失重优选不高于10%,更优选不高于7%,特别优选不高于5%。The loss on drying of the cellulose particles for pharmaceutical preparations after drying is preferably not higher than 10%, more preferably not higher than 7%, particularly preferably not higher than 5%.
在喷雾干燥完成后,如果需要的话,可以进行筛分和分粒,从而将平均粒径限制在10至400μm。从该制剂用纤维素的性质的角度来说,优选窄的粒度分布。After spray drying is complete, if necessary, sieving and sizing can be performed to limit the average particle size to 10 to 400 μm. From the viewpoint of the properties of the cellulose for formulation, a narrow particle size distribution is preferred.
本发明的制剂用纤维素粒子可以通过将包含研磨至所需粒径程度的微晶纤维素的分散液进行干燥以聚集成液滴来进行制备。因此,其具有高长宽比、高敲击堆密度、适宜的形状系数、易于调节的粒度分布、适宜的比表面积、高水汽吸附量和适宜的粒子强度。The cellulose particles for formulations of the present invention can be produced by drying a dispersion containing microcrystalline cellulose ground to a desired particle size to aggregate into droplets. Therefore, it has high aspect ratio, high tapping bulk density, suitable shape factor, easy-to-adjust particle size distribution, suitable specific surface area, high water vapor adsorption capacity and suitable particle strength.
为了将活性成分成层于该制剂用纤维素粒子上,可以使用常规的方法。可以用下面所述的方法来使活性成分成层,但该方法并非对实施本发明的方式进行限制。In order to layer the active ingredient on the cellulose particles for formulation, conventional methods can be used. The active ingredient can be layered by the method described below, but the method is not limiting of the manner in which the invention can be practiced.
即,(1)一种方法,该方法包括在用流化床造粒包衣装置(或旋转流化床型造粒包衣装置、配有武斯特氏(Wurster)柱的流化床造粒包衣装置或配有改进的武斯特氏柱的流化床造粒包衣装置)对制剂用纤维素粒子进行流化的同时,将在粘合剂的溶液中溶解或悬浮活性成分而制备的液体进行喷雾制剂用,(2)一种方法,该方法包括在离心流化型包衣装置中转动制剂用微晶纤维素粒子的同时,将粘合剂的溶液连续进行喷雾并同时将活性成分(以及赋形剂,如果需要的话)的粉末进行给料制剂用,(3)一种方法,该方法包括在用高速的混合造粒装置转动纤维素粒子的同时,添加可被粒子吸收量的活性成分和粘合剂溶液,和(4)一种方法,该方法包括将制剂用纤维素粒子浸入到活性成分和粘合剂溶液中。在任何一种方法中,当需要时,可以进行如除去干燥的聚集粒子的操作。That is, (1) a method, the method comprising using a fluidized bed granulation coating device (or rotary fluidized bed type granulation coating device, a fluidized bed granulation coating device equipped with Wuster's (Wurster) column) Granule coating equipment or a fluidized bed granulation coating equipment equipped with a modified Wuster column) while fluidizing the cellulose particles for formulation, the active ingredient will be dissolved or suspended in the solution of the binder to form The prepared liquid is used for spray formulations, (2) a method comprising continuously spraying a solution of a binder while simultaneously spraying microcrystalline cellulose particles for formulations in a centrifugal fluidized coating device A powder of the active ingredient (and excipients, if desired) for dosing formulation, (3) a method comprising adding an absorbable particle while rotating the cellulose particles with a high-speed mixing and granulating device Amounts of an active ingredient and a binder solution, and (4) a method comprising immersing cellulose particles for formulation into the active ingredient and a binder solution. In either method, when necessary, operations such as removal of dried aggregated particles may be performed.
在本发明中所用的活性成分是用于治疗、预防或诊断人或动物疾病的活性物质。The active ingredients used in the present invention are active substances for the treatment, prevention or diagnosis of human or animal diseases.
该活性成分的实例有抗癫痫药物(乙酰苯丁脲、扑痫酮等)、解热剂、镇痛剂和抗炎药物(醋氨酚、苯基乙酰基甘氨酸二甲基酰胺、双氯灭痛、羟保泰松、安乃近(sulpyrine)、布洛芬、酮洛芬、盐酸tinolidine、盐酸苄达明、盐酸噻拉米特、吡罗昔康等)、抗眩晕药物(乘晕宁、眩晕停等)、精神病药物(盐酸氯丙嗪、左旋甲丙嗪马来酸盐、培拉嗪马来酸盐、奋乃静、地西泮、奥沙西泮等)、骨骼肌松弛剂(氯唑沙宗、氯苯甘醚氨基甲酸盐、氯美扎酮、盐酸乙哌立松等)、植物性神经系统药物(氨甲酸甲胆碱、溴化新斯的明、溴化吡啶斯的明等)、解痉剂(布托溴铵(butropium bromide)、N-丁基溴化东莨菪碱、溴化丙胺太林、盐酸罂粟碱等)、抗帕金森病药(盐酸苯海索等)、抗组胺药(盐酸苯海拉明、dl-马来那敏、d-马来那敏盐、异丙嗪、美喹他嗪等)、强心剂(氨茶碱、咖啡因、dl-盐酸异丙肾上腺素、盐酸乙苯呋林等)、抗心律失常药(双异丙吡胺等)、利尿药(氯化钾、氢氯噻嗪、乙酰唑胺等)、降血压药(六甲溴铵、盐酸肼屈嗪、盐酸普萘洛尔、卡托普利、甲基多巴等)、血管扩张药(盐酸依他苯酮、盐酸卡波孟、戊四硝酯、双密达莫、枸橼酸烟胺乙酯(nicametate citrate)等)、动脉硬化药(卵磷脂等)、循环器官药(盐酸尼卡地平、盐酸甲氯芬酯、吡醇氨酯、胡泮钙(calcium hopantenate)、己酮可可碱等)、呼吸促进剂(盐酸回苏灵等)、镇咳祛痰药(氢溴酸右美沙芬、那可丁、L-半胱氨酸甲酯盐酸盐、茶碱、盐酸麻黄碱等)、利胆药(脱氢胆酸等)、消化器官药(甲氧氯普胺、多潘立酮等等)、维生素(呋喃硫胺、奥托硫胺(octotiamine)、盐酸吡哆辛、烟酸、抗坏血酸等)、抗生素类物质(红霉素、吉他霉素、交沙霉素、四环素等)及化疗药物(异烟肼、乙硫异烟胺、呋喃妥因、依诺沙星、氧氟沙星、诺氟沙星等等)。在本发明中,可以将两种或多种活性成分同时成层或在形成一层后再形成另一层。Examples of such active ingredients are antiepileptic drugs (acetophenbutamide, primidone, etc.), antipyretics, analgesics and anti-inflammatory drugs (acetaminophen, phenylacetylglycine dimethylamide, diclofenac, hydroxy Butazone, sulpyrine, ibuprofen, ketoprofen, tinolidine hydrochloride, benzydamine hydrochloride, thiramide hydrochloride, piroxicam, etc.), anti-vertigo drugs (Chengyunning, Vertigo, etc.) , psychiatric drugs (chlorpromazine hydrochloride, levomepromazine maleate, perazine maleate, perphenazine, diazepam, oxazepam, etc.), skeletal muscle relaxants (chlorzoxazone , chlorphenesin carbamate, clomezadone, eperisone hydrochloride, etc.), autonomic nervous system drugs (methacholine, neostigmine bromide, pyridostigmine bromide, etc.), Antispasmodics (butropium bromide, N-butyl scopolamine bromide, propantheline bromide, papaverine hydrochloride, etc.), antiparkinsonian drugs (trihexyphenidyl hydrochloride, etc.), antihistamines (diphenhydramine hydrochloride, dl-malenamine, d-malenamine salt, promethazine, mequitazine, etc.), cardiotonic agents (aminophylline, caffeine, dl-isoproterenol hydrochloride, Ethylfurin hydrochloride, etc.), antiarrhythmic drugs (disopyramide, etc.), diuretics (potassium chloride, hydrochlorothiazide, acetazolamide, etc.), hypotensive drugs (hexamethylammonium bromide, hydralazine hydrochloride, hydrochloric acid propranolol, captopril, methyldopa, etc.), vasodilators (etabenone hydrochloride, carbomer hydrochloride, pentyl tetranitrate, dipyridamole, nicotinamide ethyl citrate ( nicametate citrate), etc.), arteriosclerosis drugs (lecithin, etc.), circulatory organ drugs (nicardipine hydrochloride, meclofenoxate hydrochloride, pyroxate, calcium hopantenate, pentoxifylline, etc.), Respiratory accelerators (resulphin hydrochloride, etc.), antitussive and expectorant drugs (dextromethorphan hydrobromide, narcotin, L-cysteine methyl ester hydrochloride, theophylline, ephedrine hydrochloride, etc.), diuretics Bile drugs (dehydrocholic acid, etc.), gastrointestinal drugs (metoclopramide, domperidone, etc.), vitamins (furultiamine, octotiamine, pyridoxine hydrochloride, niacin, ascorbic acid, etc.) , antibiotics (erythromycin, kitasamycin, josamycin, tetracycline, etc.) and chemotherapy drugs (isoniazid, ethionamide, nitrofurantoin, enoxacin, ofloxacin, norfloxacin star, etc.). In the present invention, two or more active ingredients may be simultaneously layered or formed into another layer after forming one layer.
被成层的活性成分的量由剂量来决定。另外,这里所涉及的量指的是被成层到制剂用纤维素表面上的活性成分的量。详细地说明如下一个实施方案。当即使以极低的剂量也能预期该活性成分的作用时,以起始颗粒的重量为基础,被成层的量为约0.01重量%。当需要大剂量以获得活性成分的作用时,该量为约500重量%。The amount of active ingredient to be layered is dose dependent. In addition, the amount mentioned here refers to the amount of the active ingredient layered on the surface of the cellulose for formulation. The following embodiment will be described in detail. When the action of the active ingredient can be expected even at very low doses, the amount to be layered is about 0.01% by weight, based on the weight of the starting granules. When a large dose is required to obtain the effect of the active ingredient, this amount is about 500% by weight.
在将活性成分成层于制剂用纤维素粒子上时,该活性成分可与添加剂一起成层以易化各操作、防止活性成分在后面的操作过程中剥落、控制活性成分的溶解速率或增强稳定性。添加剂的实例有:粘合剂(例如羟丙基纤维素、羟丙基甲基纤维素、聚乙烯醇、聚乙烯基吡咯烷酮、聚乙二醇等)、薄膜包衣剂(例如苯二甲酸羟丙基甲基纤维素、醋酸琥珀酸羟丙基甲基纤维素、羧甲基纤维素、乙基纤维素、乙基纤维素水分散液、甲基丙烯酸氨基烷基酯共聚物E、甲基丙烯酸共聚物L、甲基丙烯酸共聚物S、甲基丙烯酸共聚物LD、甲基丙烯酸氨基烷基酯共聚物RS、硬化油等)、表面活性剂(例如蔗糖脂肪酸酯、聚氧乙烯聚氧化丙二醇、聚山梨醇酯、十二烷基硫酸钠等)、赋形剂(例如玉米淀粉、稻米淀粉、粉糖、乳糖、微晶纤维素、粉状纤维素、微晶纤维素和羧甲基纤维素钠等)、崩解剂(例如低置换度羟丙基纤维素、羧甲基纤维素钙、交联羧甲基纤维素钠、预胶化淀粉等)、无机物质(例如滑石、硬脂酸镁、轻质硅酸酐、合成硅酸铝、氧化钛等)、以及其它的物质。When the active ingredient is layered on the cellulose particles for formulation, the active ingredient can be layered together with additives to facilitate each operation, prevent the active ingredient from peeling off during subsequent operations, control the dissolution rate of the active ingredient, or enhance stability sex. Examples of additives are: binders (such as hydroxypropylcellulose, hydroxypropylmethylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, polyethylene glycol, etc.), film coating agents (such as hydroxyphthalic acid Propyl methyl cellulose, hydroxypropyl methyl cellulose acetate succinate, carboxymethyl cellulose, ethyl cellulose, ethyl cellulose aqueous dispersion, aminoalkyl methacrylate copolymer E, methyl Acrylic acid copolymer L, methacrylic acid copolymer S, methacrylic acid copolymer LD, aminoalkyl methacrylate copolymer RS, hardened oil, etc.), surfactants (such as sucrose fatty acid ester, polyoxyethylene polyoxy Propylene glycol, polysorbate, sodium lauryl sulfate, etc.), excipients (such as corn starch, rice starch, powdered sugar, lactose, microcrystalline cellulose, powdered cellulose, microcrystalline cellulose, and carboxymethyl cellulose sodium, etc.), disintegrants (such as low-substituted hydroxypropyl cellulose, carmellose calcium, croscarmellose sodium, pregelatinized starch, etc.), inorganic substances (such as talc, hard Magnesium fatty acid, light silicic anhydride, synthetic aluminum silicate, titanium oxide, etc.), and other substances.
在活性成分成层中所用的介质不受限制。可以使用水、乙醇以及其它适于制剂用的有机溶剂。可以使用通过将活性成分和粘合剂溶解或分散于溶剂中而制备的液体来进行成层。The medium used in the layering of the active ingredient is not limited. Water, ethanol, and other organic solvents suitable for formulation can be used. Layering can be performed using a liquid prepared by dissolving or dispersing an active ingredient and a binder in a solvent.
一种优选的方式如下。为了改善服用的难易程度、改善外观、防潮、抗氧化、调节活性成分的溶解速率(例如制备控释药物或肠溶药物)或掩盖活性成分的苦味或气味,可以将水性涂膜或溶剂涂膜应用于通过将活性成分成层于本发明的纤维素粒子上制得的颗粒上。A preferred method is as follows. In order to improve the ease of administration, improve the appearance, moisture-proof, anti-oxidation, adjust the dissolution rate of active ingredients (for example, to prepare controlled-release drugs or enteric-coated drugs), or to mask the bitter taste or odor of active ingredients, water-based coatings or solvent coatings can be used. Films are applied to granules prepared by layering the active ingredient onto the cellulose particles of the invention.
用于该类膜包衣的薄膜包衣剂可以是常规的薄膜包衣剂。其实例有水溶性薄膜包衣剂(例如甲基丙烯酸氨基烷基酯共聚物E、羟丙基纤维素、羟丙基甲基纤维素等)、控释薄膜包衣剂(例如乙基纤维素、乙基纤维素水分散液、甲基丙烯酸共聚物S、甲基丙烯酸氨基烷基酯共聚物RS、丙烯酸乙酯-甲基丙烯酸甲酯共聚物乳剂等)、和肠溶薄膜包衣剂(例如苯二甲酸羟丙基甲基纤维素、醋酸琥珀酸羟丙基甲基纤维素、羧甲基乙基纤维素、甲基丙烯酸共聚物L、甲基丙烯酸共聚物LD、甲基丙烯酸共聚物S等等)。此外,可以单独使用上述的包衣剂或组合使用两种或多种上述的包衣剂来进行包衣,如果需要的话,还可以同时使用其它的水溶性材料从而来完成掩盖苦味、掩盖气味、防潮和抗氧化的目的。但是,薄膜包衣剂并不仅限于这里所列的薄膜包衣剂。The film coating agent used for this type of film coating may be a conventional film coating agent. Examples thereof are water-soluble film coating agents (such as aminoalkyl methacrylate copolymer E, hydroxypropyl cellulose, hydroxypropyl methylcellulose, etc.), controlled-release film coating agents (such as ethyl cellulose , ethyl cellulose aqueous dispersion, methacrylic acid copolymer S, aminoalkyl methacrylate copolymer RS, ethyl acrylate-methyl methacrylate copolymer emulsion, etc.), and enteric film coating agent ( For example, hydroxypropylmethylcellulose phthalate, hydroxypropylmethylcellulose acetate succinate, carboxymethylethylcellulose, methacrylic acid copolymer L, methacrylic acid copolymer LD, methacrylic acid copolymer S, etc.). In addition, the above-mentioned coating agents can be used alone or in combination of two or more of the above-mentioned coating agents for coating. If necessary, other water-soluble materials can also be used at the same time to complete the masking of bitterness, odor, Moisture-proof and anti-oxidation purpose. However, the film coating agents are not limited to those listed here.
为涂敷含有上述薄膜包衣剂的膜,可以使用常规的手段。常规手段有流化床造粒包衣装置、配有武斯特氏柱的流化床造粒包衣装置或配有改进的武斯特氏柱的流化床造粒包衣装置、离心的流化床型造粒包衣装置和旋转流化床型造粒包衣装置。For coating the films containing the abovementioned film coating agents, conventional means can be used. Conventional means include fluidized bed granulation coating equipment, fluidized bed granulation coating equipment equipped with Wuster column or fluidized bed granulation coating equipment equipped with improved Wuster column, centrifugal Fluidized bed type granulation coating equipment and rotary fluidized bed type granulation coating equipment.
本发明的带有成层的活性成分的颗粒或为了控制溶解速率等目的而对带有成层的活性成分的颗粒进行膜包衣而获得的膜包衣的颗粒可以直接进行给药。或者可以在将其胶囊化后进行给药或可以与其它的药物混合进行给药。或者,它们可以与其它的赋形剂、活性成分、包含活性成分的颗粒或膜包衣的颗粒进行混合,然后可以将其制备成片剂从而以包含颗粒的片剂的形式被应用。The layered active ingredient-carrying granules of the present invention or film-coated granules obtained by film-coating the layered active ingredient-carrying granules for the purpose of controlling the dissolution rate and the like can be directly administered. Alternatively, it may be administered after being encapsulated or mixed with other drugs. Alternatively, they can be mixed with other excipients, active ingredients, active ingredient-containing granules or film-coated granules, which can then be prepared into tablets to be used in the form of granule-containing tablets.
用于测定制剂用纤维素粒子的方法概括如下:The method used for the determination of cellulose particles for pharmaceutical formulations is summarized as follows:
·微晶纤维素的聚合度· Degree of polymerization of microcrystalline cellulose
使用第13版日本药典中所叙述的微晶纤维素确定试验(3)。The test for determination of microcrystalline cellulose described in the Japanese Pharmacopoeia, 13th edition (3) was used.
·经研磨的粒子的粒径[μm]・Particle size of ground particles [μm]
将干燥前的纤维素水分散液用水进行稀释从而获得一种表现出具有适宜透光度的浓度,进行一分钟的超声后,在对该进行了稀释的分散液进行搅拌的同时用激光衍射型粒径分布分析器(LA-910型,由Horiba,Ltd.制造)在相对折光率为1.2和摄取次数为10的条件下测定基于体积的平均粒径。Dilute the cellulose aqueous dispersion before drying with water to obtain a concentration that exhibits a suitable light transmittance, and after ultrasonication for one minute, use a laser diffraction type laser while stirring the diluted dispersion. A particle size distribution analyzer (LA-910 type, manufactured by Horiba, Ltd.) measures the volume-based average particle size under the conditions of a relative refractive index of 1.2 and an uptake number of 10.
·pH·pH
将干燥前的纤维素水分散液调整至25℃,随后用玻璃电极型氢离子密度计(D-21型,由Horiba,Ltd.制造)来测定其pH值。The aqueous cellulose dispersion before drying was adjusted to 25°C, and then its pH was measured with a glass electrode type hydrogen ion density meter (D-21 type, manufactured by Horiba, Ltd.).
·电导率(IC)[μS/cm]·Conductivity (IC)[μS/cm]
将干燥前的纤维素水分散液调整至25℃,随后用电导率测定装置(D-21型,由Horiba,Ltd.制造)来测定其电导率。The aqueous cellulose dispersion before drying was adjusted to 25° C., and then its electrical conductivity was measured with an electrical conductivity measuring device (D-21 model, manufactured by Horiba, Ltd.).
·制剂用纤维素粒子的敲击堆密度· Tapping bulk density of cellulose particles for formulations
将30克粒子粗略填充到一个100ml的玻璃量筒中,然后在低冲击性的支撑物如覆盖有橡胶层的桌子上进行手动敲击。进行敲击,使该量筒从几厘米的高度垂直落到该支撑物上直至粒子不再被压缩。在完成敲击后,测定该粒子层的体积并将其除以30。重复测定三次,将结果进行平均。Thirty grams of particles are roughly filled into a 100ml glass graduated cylinder and tapped manually on a low-impact support such as a rubber-covered table. The cylinder is tapped and dropped vertically onto the support from a height of a few centimeters until the particles are no longer compressed. After tapping is complete, measure the volume of the particle layer and divide it by 30. The determination was repeated three times and the results were averaged.
·制剂用纤维素粒子的长宽比·Aspect ratio of cellulose particles for formulation
将用数字显微镜(带有VH-501透镜的VH-7000型,由KEYENCECo.制造)摄制的图像以TIFF文件的形式进行储存,象素为1360×1024,然后用图像处理分析软件(Image Hyper II,由DegiMo Co.开发),对100个粒子进行处理以获得其横截面的长宽比(短径/长径),然后对所得结果进行平均。Images taken with a digital microscope (type VH-7000 with VH-501 lens, manufactured by KEYENCE Co.) were stored in the form of TIFF files with a pixel size of 1360 × 1024, and then processed and analyzed with an image processing software (Image Hyper II , developed by DegiMo Co.), 100 particles were processed to obtain the aspect ratio (short diameter/long diameter) of their cross-sections, and the obtained results were averaged.
·制剂用纤维素的形状系数·Shape factor of cellulose for preparation
将用数字显微镜(带有VH-501透镜的VH-7000型,由KEYENCECo.制造)摄制的图像以TIFF文件的形式进行储存,象素为1360×1024,然后用图像处理分析软件,对100个粒子进行处理以获得其形状系数,然后对所得结果进行平均。可以用如下的方程式来获得形状系数。当一个球上无凸凹时,该值为1。随凸凹增加该值增加,即大于1。Images taken with a digital microscope (type VH-7000 with VH-501 lens, manufactured by KEYENCE Co.) were stored in the form of TIFF files with a pixel size of 1360×1024, and then image processing and analysis software was used to analyze 100 Particles are processed to obtain their shape coefficients, and the results are averaged. The shape factor can be obtained using the following equation. The value is 1 when there is no bump on a ball. This value increases as the bump increases, i.e. greater than 1.
形状系数=(粒子的周长)2/(4π×(粒子面积的总和)Shape factor = (perimeter of particle) 2 / (4π × (sum of particle area)
·制剂用纤维素粒子的平均尺寸[μm]・Average size of cellulose particles for pharmaceutical preparations [μm]
使用Ro-Tap筛振动器(A型筛振动器,由Hirako Seisaku-shoCo.,Ltd.制造),用JIS标准筛(Z8801-1987)将样品(30g)筛分15分钟,从而测定粒度分布。将所累积的50重量%的粒度作为平均粒径。重复测量三次,将所得结果进行平均。Using a Ro-Tap sieve shaker (A type sieve shaker, manufactured by Hirako Seisaku-sho Co., Ltd.), a sample (30 g) was sieved with a JIS standard sieve (Z8801-1987) for 15 minutes to measure the particle size distribution. The cumulative particle size of 50% by weight was taken as the average particle size. The measurements were repeated three times and the results obtained were averaged.
在制剂用纤维素的平均粒径小于38μm时,将粒子分散于水中。其后,按照上述经研磨的粒子的粒径的测定方法来测定其平均粒径。When the average particle size of the cellulose for formulation is less than 38 μm, the particles are dispersed in water. Thereafter, the average particle diameter thereof was measured according to the above-mentioned method for measuring the particle diameter of the ground particles.
·制剂用纤维素粒子的比表面积・Specific surface area of cellulose particles for formulation
在105℃下,在鼓风恒温干燥器(FC-610型,由Toyo SeisakushoKaisha,Ltd.制造)中将样品干燥3小时,并将其以确保风流路的方式进料到一个测定室(measurement cell)中。该室被安装于一个流动式比表面积自动测定装置(Flowsorb 2300,由Shimadzu Corporation制造)的脱气部上,然后用夹套式加热器在120℃下脱气15分钟。在除去附着在室内壁上的水汽后,以氮气/(氮气+氦气)=0.3的流量比来测定比表面积。重复测定三次,将所得的结果进行平均。The sample was dried at 105°C for 3 hours in a blast constant temperature dryer (FC-610 type, manufactured by Toyo Seisakusho Kaisha, Ltd.), and fed into a measurement cell in such a manner that the wind flow path was ensured. )middle. The chamber was installed on a degassing section of a flow type automatic specific surface area measuring device (Flowsorb 2300, manufactured by Shimadzu Corporation), and then degassed at 120°C for 15 minutes with a jacketed heater. The specific surface area was measured at a flow ratio of nitrogen/(nitrogen+helium)=0.3 after removing moisture adhering to the chamber wall. The determination was repeated three times and the results obtained were averaged.
·制剂用纤维素粒子的水汽吸附· Moisture adsorption of cellulose particles for preparations
在105℃下,在鼓风恒温干燥器中将样品干燥3小时。其后,将样品(约30g)放置于动态蒸汽吸收测定装置(DVS-1型,由SurfaceMeasurement Systems Ltd.制造)中,然后在25℃、氮气气氛和0%的相对湿度(RH)的设定条件下进行干燥,直至粒子的重量充分达到恒重(重量波动不高于0.02%)。其后,将相对湿度设定于5%RH,将其放置至平衡(重量波动不超过0.02%)。随后,将相对湿度设定于10%,将其放置至平衡(重量波动不超过0.02%)。其后,每次将相对湿度改变5%,重复进行该操作,即在15%RH、20%RH、25%RH、30%RH和35%RH重复进行该过程,从而求出在30%相对湿度下的粒子重量和0%相对湿度下的粒子重量间的差。该重量差与0%相对湿度下粒子重量的比被定义为水汽吸附量。重复测定三次,将所得结果进行平均。The samples were dried at 105° C. for 3 hours in a forced air constant temperature dryer. Thereafter, the sample (about 30 g) was placed in a dynamic vapor absorption measuring device (DVS-1 type, manufactured by Surface Measurement Systems Ltd.), and then set at 25° C., a nitrogen atmosphere, and a relative humidity (RH) of 0%. Drying is carried out under the same conditions until the weight of the particles fully reaches a constant weight (the weight fluctuation is not higher than 0.02%). Thereafter, the relative humidity was set at 5% RH, and it was left to equilibrium (weight fluctuation not exceeding 0.02%). Subsequently, the relative humidity was set at 10%, and it was brought to equilibrium (weight fluctuation not exceeding 0.02%). Thereafter, each time the relative humidity is changed by 5%, the operation is repeated, that is, the process is repeated at 15%RH, 20%RH, 25%RH, 30%RH and 35%RH, thereby obtaining the relative humidity at 30% The difference between the particle weight at humidity and the particle weight at 0% relative humidity. The ratio of this weight difference to the particle weight at 0% relative humidity was defined as the water vapor adsorption. The determination was repeated three times and the results obtained were averaged.
·制剂用纤维素的负荷峰值·Peak loading of cellulose for formulations
这些值是用颗粒强度测定装置(GRANO,由Okada Seiko Co.,Ltd制造),在250μm/秒的测定速度下来进行测定的,将相对位移和负荷的波形中倾斜的拐点作为该负荷值。在所测粒子粒径的小于或等于50%的位移处,将在颗粒强度测定仪器的顶端小片(chip)的最小移动距离(1μm)的两倍或三倍的位移宽度内所观察到的没有负荷变化的点、或在相同位移宽度内负荷开始下降的第一个点作为拐点。测定一百个颗粒的拐点,然后将其进行平均。These values were measured with a grain strength measuring device (GRANO, manufactured by Okada Seiko Co., Ltd.) at a measuring speed of 250 μm/sec, and the inflection point of the slope in the relative displacement and load waveform was taken as the load value. At a displacement of less than or equal to 50% of the particle size of the measured particle, there will be no observations within the displacement width of two or three times the minimum moving distance (1 μm) of the top chip (chip) of the particle strength measuring instrument. The point at which the load changes, or the first point at which the load begins to drop within the same displacement width, is taken as the point of inflection. The inflection point is determined for one hundred particles and then averaged.
·制剂用纤维素粒子的休止角(°)・Angle of repose of cellulose particles for formulations (°)
用粉末测定仪(PT-R型,由Hosokawamicron Co.制造)来进行测定并且重复测定三次。将所得结果进行平均。The measurement was performed with a powder analyzer (PT-R type, manufactured by Hosokawamicron Co.) and the measurement was repeated three times. The obtained results were averaged.
将参考下面的实施例来对本发明进行详细的解释。The present invention will be explained in detail with reference to the following examples.
实施例1Example 1
将市售的牛皮纸浆(在下文中简称为KP)切割成碎片,然后在105℃的10%盐酸水溶液中水解30分钟。将所得的酸不溶性残余物过滤,然后用水进行洗涤,得到固体浓度为约40%的微晶纤维素的饼状产物。发现该饼状产物具有153的聚合度。如表1所示,该聚合度与通过将该饼状产物进行研磨和干燥所得的粒子的聚合度相同。将该饼状产物用万能混合搅拌机(5DM-03R型,由Sanei Seisakujo Co.制造)研磨1小时。向其中加入水。用均化混合器(T.K.HOMO MIXER MARK2II型,由TokushuKika Kogyo Co.,Ltd.制造)将经研磨的饼状产物和水的混合物制备成固体含量为12.5重量%的纤维素分散液。在对粒径、pH和IC进行调节后,用约8cm的旋转盘将该分散液喷雾干燥,干燥操作条件为圆盘转速为约5000rpm,流量为约6l/小时,给气温度为约170℃,排气温度为约85℃。用网眼为177μm的筛网除去粗大的粒子,然后通过使其通过网眼为75μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子A。干燥前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子A的物理性质如表1所示。Commercially available kraft pulp (abbreviated as KP hereinafter) was cut into pieces, and then hydrolyzed in 10% hydrochloric acid aqueous solution at 105° C. for 30 minutes. The resulting acid-insoluble residue was filtered and washed with water to obtain a cake-like product of microcrystalline cellulose having a solids concentration of about 40%. The cake-like product was found to have a degree of polymerization of 153. As shown in Table 1, the degree of polymerization was the same as that of particles obtained by grinding and drying the cake-like product. The cake-like product was ground with a universal mixer (5DM-03R type, manufactured by Sanei Seisakujo Co.) for 1 hour. Add water to it. A mixture of the pulverized cake product and water was prepared with a homomixer (T.K.HOMO MIXER MARK2II type, manufactured by TokushuKika Kogyo Co., Ltd.) into a cellulose dispersion having a solid content of 12.5% by weight. After adjusting the particle size, pH and IC, the dispersion is spray-dried with a rotating disk of about 8 cm. The drying operating conditions are that the rotation speed of the disk is about 5000 rpm, the flow rate is about 6 l/hour, and the air supply temperature is about 170 ° C. , the exhaust temperature is about 85°C. Coarse particles were removed with a mesh of 177 μm, and then fine particles were removed by passing through a mesh of 75 μm. Thus, cellulose particles A for formulations were obtained. Table 1 shows the particle size of the ground particles in the cellulose dispersion before drying and the physical properties of the cellulose particles A for formulation.
实施例2Example 2
向实施例1的经研磨的饼状产物中加入水,用均化混合器将该混合物制备成固体含量为15重量%的纤维素分散液。在对粒径、pH和IC进行调节后,按照与实施例1相同的条件将该分散液喷雾干燥。用网眼为212μm的筛网除去粗大的粒子,然后通过使其通过网眼为75μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子B。干燥前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子B的物理性质如表1所示。Water was added to the ground cake-like product of Example 1, and the mixture was prepared into a cellulose dispersion having a solids content of 15% by weight using a homomixer. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1. Coarse particles were removed with a mesh of 212 μm, and then fine particles were removed by passing through a mesh of 75 μm. Thus, cellulose particles B for formulations were obtained. Table 1 shows the particle diameters of the ground particles in the cellulose dispersion before drying and the physical properties of the cellulose particles B for pharmaceutical preparations.
实施例3Example 3
向实施例1所得的固体含量为40%的饼状产物中加入水,用均化混合器将该混合物制备成固体含量为约10重量%的纤维素分散液。在120MPa的压力下使该分散液通过高压破碎机(MICROFLUIDIZERM-610型,由Microfluidics Co.制造)三次,从而完成该破碎处理。在对粒径、pH和IC进行调节后,按照与实施例1相同的条件将该分散液喷雾干燥,只是将供气温度变为180℃。用网眼为75μm的筛网除去粗大的粒子,然后用网眼为45μm的筛网除去细小的粒子。从而获得制剂用纤维素粒子C。干燥前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子C的物理性质如表1所示。Water was added to the cake-like product having a solid content of 40% obtained in Example 1, and the mixture was prepared into a cellulose dispersion having a solid content of about 10% by weight using a homomixer. The dispersion was passed through a high-pressure crusher (MICROFLUIDIZERM-610 type, manufactured by Microfluidics Co.) three times under a pressure of 120 MPa, thereby completing the crushing treatment. After adjusting the particle size, pH, and IC, the dispersion was spray-dried under the same conditions as in Example 1, except that the air supply temperature was changed to 180°C. Coarse particles were removed with a mesh of 75 μm, and fine particles were removed with a mesh of 45 μm. Thus, cellulose particles C for formulations were obtained. Table 1 shows the particle diameters of the ground particles in the cellulose dispersion before drying and the physical properties of the cellulose particles C for pharmaceutical preparations.
实施例4Example 4
向实施例1所得的经研磨的饼状产物中加入水,用均化混合器将该混合物制备成固体含量为约18重量%的纤维素分散液。在对粒径、pH和IC进行调节后,按照与实施例1相同的条件将该分散液喷雾干燥。用网眼为212μm的筛网除去粗大的粒子,然后通过使其通过网眼为106μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子D。干燥前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子D的物理性质如表1所示。Water was added to the ground cake product obtained in Example 1, and the mixture was prepared into a cellulose dispersion having a solids content of about 18% by weight using a homomixer. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1. Coarse particles were removed with a mesh of 212 μm, and fine particles were removed by passing through a mesh of 106 μm. Thus, cellulose particles D for formulations were obtained. Table 1 shows the particle diameters of the ground particles in the cellulose dispersion before drying and the physical properties of the cellulose particles D for pharmaceutical preparations.
实施例5Example 5
将市售的溶解纸浆(在下文中简称为DP)切割成碎片,然后将其用105℃的10%盐酸水溶液水解10分钟。将所得的酸不溶性残余物过滤,然后用水进行洗涤,得到固体浓度为约40%的微晶纤维素的饼状产物。将该饼状产物用万能混合搅拌机研磨1小时。向其中加入水。用均化混合器将该经研磨的饼状产物和水的混合物制备成固体含量为15重量%的纤维素分散液。在120MPa的压力下使该分散液通过高压破碎机三次,从而完成破碎处理。在对粒径、pH和IC进行调节后,按照与实施例1相同的条件对该分散液进行喷雾干燥,只是将旋转盘的旋转速度变为4000rpm。用网眼为300μm的筛网除去粗大的粒子,然后用网眼为177μm的筛网除去细小的粒子。从而获得制剂用纤维素粒子E。干燥前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子E的物理性质如表1所示。Commercially available dissolving pulp (abbreviated as DP hereinafter) was cut into chips, which were then hydrolyzed with 10% hydrochloric acid aqueous solution at 105° C. for 10 minutes. The resulting acid-insoluble residue was filtered and washed with water to obtain a cake-like product of microcrystalline cellulose having a solids concentration of about 40%. The cake-like product was ground with a universal mixer for 1 hour. Add water to it. A mixture of the ground cake product and water was prepared with a homomixer to give a cellulose dispersion having a solids content of 15% by weight. The dispersion was passed through a high-pressure crusher three times under a pressure of 120 MPa, thereby completing the crushing process. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1, except that the rotation speed of the rotary disk was changed to 4000 rpm. Coarse particles were removed with a mesh of 300 μm, and fine particles were removed with a mesh of 177 μm. Thus, cellulose particles E for formulations were obtained. Table 1 shows the particle diameters of the ground particles in the cellulose dispersion before drying and the physical properties of the cellulose particles E for pharmaceutical preparations.
实施例6Example 6
将市售的KP切割成碎片,然后将其用105℃的10%盐酸水溶液水解60分钟。将所得的酸不溶性残余物过滤,然后用水进行洗涤,得到固体浓度为约40%的微晶纤维素的饼状产物。将该饼状产物用万能混合搅拌机研磨1小时。向其中加入水。用均化混合器将该经研磨的饼状产物和水的混合物制备成固体含量为13重量%的纤维素分散液。在120MPa的压力下使该分散液通过高压破碎机三次,从而完成破碎处理。在对粒径、pH和IC进行调节后,按照与实施例1相同的条件对该分散液进行喷雾干燥。用网眼为150μm的筛网除去粗大的粒子,然后通过使其通过网眼为63μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子F。干燥前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子F的物理性质如表1所示。Commercially available KP was cut into pieces, which were then hydrolyzed with 10% aqueous hydrochloric acid at 105°C for 60 minutes. The resulting acid-insoluble residue was filtered and washed with water to obtain a cake-like product of microcrystalline cellulose having a solids concentration of about 40%. The cake-like product was ground with a universal mixer for 1 hour. Add water to it. A mixture of the ground cake product and water was prepared with a homomixer to give a cellulose dispersion having a solids content of 13% by weight. The dispersion was passed through a high-pressure crusher three times under a pressure of 120 MPa, thereby completing the crushing process. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1. Coarse particles were removed with a mesh of 150 μm, and then fine particles were removed by passing through a mesh of 63 μm. Thus, cellulose particles F for formulations were obtained. Table 1 shows the particle diameters of the ground particles in the cellulose dispersion before drying and the physical properties of the cellulose particles F for pharmaceutical preparations.
实施例7Example 7
将市售的DP切割成碎片,然后用105℃的3%盐酸水溶液水解15分钟。将所得的酸不溶性残余物过滤,然后用水进行洗涤,得到固体浓度为约40%的微晶纤维素的饼状产物。将该饼状产物用万能混合搅拌机研磨1小时。向其中加入水。用均化混合器将该经研磨的饼状产物和水的混合物制备成固体含量为15重量%的纤维素分散液。在对粒径、pH和IC进行调节后,按照与实施例1相同的条件对该分散液进行喷雾干燥。用网眼为300μm的筛网除去粗大的粒子,然后通过使其通过网眼为75μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子G。干燥前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子G的物理性质如表2所示。Commercially available DP was cut into pieces and then hydrolyzed with 3% aqueous hydrochloric acid at 105 °C for 15 min. The resulting acid-insoluble residue was filtered and washed with water to obtain a cake-like product of microcrystalline cellulose having a solids concentration of about 40%. The cake-like product was ground with a universal mixer for 1 hour. Add water to it. A mixture of the ground cake product and water was prepared with a homomixer to give a cellulose dispersion having a solids content of 15% by weight. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1. Coarse particles were removed with a mesh of 300 μm, and then fine particles were removed by passing through a mesh of 75 μm. Thus, cellulose particles G for formulations were obtained. Table 2 shows the particle size of the ground particles in the cellulose dispersion before drying and the physical properties of the cellulose particles G for formulation.
实施例8Example 8
用万能混合搅拌机将实施例7所得的饼状产物研磨30分钟。向其中加入水。用均化混合器将该经研磨的饼状产物和水的混合物制备成固体含量为20重量%的纤维素分散液。在对粒径、pH和IC进行调节后,按照与实施例1相同的条件对该分散液进行喷雾干燥,只是将流量变为约6.5l/小时并且将旋转盘的旋转速度变为2000rpm。用网眼为420μm的筛网除去粗大的粒子,然后通过使其通过网眼为350μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子H。干燥前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子H的物理性质如表2所示。The cake-like product obtained in Example 7 was ground for 30 minutes with a universal mixer. Add water to it. A mixture of the ground cake product and water was prepared with a homomixer to give a cellulose dispersion having a solids content of 20% by weight. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1 except that the flow rate was changed to about 6.5 l/hour and the rotation speed of the rotary disk was changed to 2000 rpm. Coarse particles were removed with a mesh of 420 μm, and then fine particles were removed by passing through a mesh of 350 μm. Thus, cellulose particles H for pharmaceutical preparations were obtained. Table 2 shows the particle size of the ground particles in the cellulose dispersion before drying and the physical properties of the cellulose particles H for formulation.
实施例9Example 9
向实施例1的经研磨的饼状物中加入水,然后用均化混合器将该混合物制备成固体含量为14重量%的纤维素分散液。在对粒径、pH和IC进行调节后,将该分散液与12重量%的乳糖水溶液进行混合,混合比例为1000g分散液比500g乳糖水溶液,然后按照与实施例1相同的条件对该混合物进行喷雾干燥。用网眼为212μm的筛网除去粗大的粒子,然后通过使其通过网眼为75μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子I。加入乳糖水溶液前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子I的物理性质如表2所示。Water was added to the milled cake of Example 1, and the mixture was prepared into a cellulose dispersion having a solids content of 14% by weight using a homomixer. After adjusting the particle size, pH and IC, the dispersion was mixed with 12% by weight of lactose aqueous solution, the mixing ratio was 1000g dispersion to 500g lactose aqueous solution, and then the mixture was subjected to the same conditions as in Example 1. Spray dry. Coarse particles were removed with a mesh of 212 μm, and then fine particles were removed by passing through a mesh of 75 μm. Thus, the cellulose particles I for pharmaceutical preparations were obtained. Table 2 shows the particle diameters of the ground particles in the cellulose dispersion before adding the lactose aqueous solution and the physical properties of the cellulose particles I for pharmaceutical preparations.
实施例10Example 10
向实施例1的经研磨的饼状物中加入水,然后用均化混合器将该混合物制备成固体含量为9重量%的纤维素分散液。在对粒径、pH和IC进行调节后,将该分散液与9重量%的乳糖水溶液进行混合,混合比例为1000g分散液比1000g乳糖水溶液,然后按照与实施例1相同的条件对该混合物进行喷雾干燥,只是将给气温度变为约180℃。用网眼为150μm的筛网除去粗大的粒子,然后通过使其通过网眼为63μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子J。加入乳糖水溶液前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子J的物理性质如表2所示。Water was added to the ground cake of Example 1, and the mixture was prepared into a cellulose dispersion having a solids content of 9% by weight using a homomixer. After adjusting the particle size, pH and IC, the dispersion was mixed with 9% by weight of lactose aqueous solution, the mixing ratio was 1000g dispersion to 1000g lactose aqueous solution, and then the mixture was subjected to the same conditions as in Example 1. Spray drying, just change the feed air temperature to about 180°C. Coarse particles were removed with a mesh of 150 μm, and then fine particles were removed by passing through a mesh of 63 μm. Thus, cellulose particles J for formulations were obtained. Table 2 shows the particle diameters of the ground particles in the cellulose dispersion before the addition of the lactose aqueous solution and the physical properties of the cellulose particles J for pharmaceutical preparations.
实施例11Example 11
向实施例1的经研磨的饼状物中加入水,然后用均化混合器将该混合物制备成固体含量为8重量%的纤维素分散液。在对粒径、pH和IC进行调节后,将该分散液与17.1重量%的乳糖水溶液和3重量%的羟丙基纤维素(L型,由Nippon Soda Co.,Ltd.制造)水溶液进行混合,混合比例为500g分散液比900g乳糖溶液比200g羟丙基纤维素溶液,然后按照与实施例1相同的条件对该混合物进行喷雾干燥,只是将给气温度变为约180℃。用网眼为150μm的筛网除去粗大的粒子,然后通过使其通过网眼为75μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子K。加入乳糖水溶液前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子K的物理性质如表2所示。Water was added to the ground cake of Example 1, and the mixture was prepared into a cellulose dispersion having a solids content of 8% by weight using a homomixer. After adjusting the particle diameter, pH and IC, the dispersion was mixed with a 17.1% by weight aqueous solution of lactose and a 3% by weight aqueous solution of hydroxypropylcellulose (L type, manufactured by Nippon Soda Co., Ltd.) , the mixing ratio was 500g dispersion liquid to 900g lactose solution to 200g hydroxypropyl cellulose solution, and then the mixture was spray-dried according to the same conditions as in Example 1, except that the air supply temperature was changed to about 180°C. Coarse particles were removed with a mesh of 150 μm, and then fine particles were removed by passing through a mesh of 75 μm. Thus, cellulose particles K for formulations were obtained. Table 2 shows the particle size of the ground particles in the cellulose dispersion before adding the lactose aqueous solution and the physical properties of the cellulose particles K for formulation.
实施例12Example 12
向实施例1的经研磨的饼状物中加入水,然后用均化混合器将该混合物制备成固体含量为14.7重量%的纤维素分散液。在对粒径、pH和IC进行调节后,将该分散液与1.5重量%的羟丙基纤维素(L型,由Nippon Soda Co.,Ltd.制造)水溶液进行混合,混合比例为1000g分散液比200g羟丙基纤维素水溶液,然后在与实施例1相同的条件下对该混合物进行喷雾干燥。用网眼为300μm的筛网除去粗大的粒子,然后通过使其通过网眼为150μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子L。加入羟丙基纤维素水溶液前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子L的物理性质如表2所示。Water was added to the milled cake of Example 1, and the mixture was prepared into a cellulose dispersion having a solids content of 14.7% by weight using a homomixer. After adjusting the particle diameter, pH and IC, the dispersion was mixed with a 1.5% by weight aqueous solution of hydroxypropyl cellulose (L type, manufactured by Nippon Soda Co., Ltd.) in a mixing ratio of 1000 g of the dispersion Than 200g hydroxypropyl cellulose aqueous solution, then under the same conditions as in Example 1, the mixture was spray-dried. Coarse particles were removed with a mesh of 300 μm, and then fine particles were removed by passing through a mesh of 150 μm. Thus, cellulose particles L for formulations were obtained. Table 2 shows the particle diameters of the ground particles in the cellulose dispersion before adding the aqueous hydroxypropylcellulose solution and the physical properties of the cellulose particles L for formulation.
实施例13Example 13
将实施例1所得的固体含量为约40%的饼状产物用万能混合机研磨90分钟。向经研磨的饼状产物中加入水,然后用均化混合器将该混合物制备成固体含量为3重量%的纤维素分散液。在对粒径、pH和IC进行调节后,使用与实施例1相同的旋转盘将该分散液进行喷雾干燥,所用干燥操作条件为旋转盘旋转速度为约25000rpm,流量为约3l/小时,给气温度为约180℃,排气温度为约85℃。用网眼为38μm的筛网除去粗大的粒子,从而获得制剂用纤维素粒子M。发现该制剂用纤维素粒子M具有0.62g/ml的敲击堆密度。该纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子M的物理性质如表3所示。The cake-like product with a solid content of about 40% obtained in Example 1 was ground with a universal mixer for 90 minutes. Water was added to the ground cake product, and the mixture was prepared into a cellulose dispersion having a solid content of 3% by weight using a homomixer. After adjusting the particle size, pH and IC, the dispersion was spray-dried using the same rotating disk as in Example 1. The drying operating conditions used were that the rotating speed of the rotating disk was about 25000 rpm, and the flow rate was about 3 l/hour. The air temperature is about 180°C and the exhaust temperature is about 85°C. Coarse particles were removed by a sieve with a mesh size of 38 μm to obtain cellulose particles M for pharmaceutical preparations. The cellulose particles M for formulation were found to have a tapped bulk density of 0.62 g/ml. Table 3 shows the particle size of the ground particles in the cellulose dispersion and the physical properties of the cellulose particles M for formulation.
实施例14Example 14
用万能混合搅拌机将实施例6所得的饼状产物研磨1小时。向经研磨的饼状产物中加入水,然后用均化混合器将该混合物制备成固体含量为15%的纤维素分散液。在120MPa的压力下使该分散液通过高压破碎机三次,从而完成破碎处理。在对粒径、pH和IC进行调节后,在与实施例1相同的条件下对该分散液进行喷雾干燥,只是将旋转盘的旋转速度变为4000rpm。用网眼为212μm的筛网除去粗大的粒子,然后用网眼为75μm的筛网除去细小的颗粒。从而获得制剂用纤维素粒子N。发现该制剂用纤维素粒子N具有0.62g/ml的敲击堆密度。该纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子N的物理性质如表3所示。The cake-like product obtained in Example 6 was ground for 1 hour with a universal mixer. Water was added to the ground cake product, and the mixture was prepared into a cellulose dispersion having a solids content of 15% using a homomixer. The dispersion was passed through a high-pressure crusher three times under a pressure of 120 MPa, thereby completing the crushing process. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1 except that the rotation speed of the rotary disk was changed to 4000 rpm. Coarse particles were removed with a mesh of 212 μm, and fine particles were removed with a mesh of 75 μm. Thus, cellulose particles N for formulations were obtained. The cellulose particles N for the formulation were found to have a tapped bulk density of 0.62 g/ml. Table 3 shows the particle diameters of the ground particles in the cellulose dispersion and the physical properties of the cellulose particles N for formulation.
实施例15Example 15
向实施例1的经研磨的饼状物中加入水,然后用均化混合器将该混合物制备成固体含量为10.0重量%的纤维素分散液。在对粒径、pH和IC进行调节后,将该分散液与10.0重量%的乳糖水溶液、10.0重量%的玉米淀粉分散液和5.0重量%的羟丙基纤维素(L型,由NipponSoda Co.,Ltd.制造)进行混合,混合比例为300g分散液对200g乳糖溶液、480g的玉米淀粉分散液和40g的羟丙基纤维素,然后在与实施例1相同的条件下对该混合物进行喷雾干燥,只是将给气温度变为180℃。用网眼为150μm的筛网除去粗大的粒子,然后通过使其通过网眼为75μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子O。加入乳糖水溶液前的纤维素分散液中的经研磨粒子的粒径和制剂用纤维素粒子O的物理性质如表3所示。Water was added to the ground cake of Example 1, and the mixture was prepared into a cellulose dispersion having a solids content of 10.0% by weight using a homomixer. After adjusting the particle size, pH and IC, the dispersion was mixed with 10.0% by weight of lactose aqueous solution, 10.0% by weight of corn starch dispersion and 5.0% by weight of hydroxypropyl cellulose (L type, produced by NipponSoda Co. , Ltd.) to mix, the mixing ratio is 300g dispersion to 200g lactose solution, 480g cornstarch dispersion and 40g hydroxypropyl cellulose, then the mixture is spray-dried under the same conditions as in Example 1 , just change the air supply temperature to 180°C. Coarse particles were removed with a mesh of 150 μm, and then fine particles were removed by passing through a mesh of 75 μm. Thus, cellulose particles O for formulations were obtained. Table 3 shows the particle size of the ground particles in the cellulose dispersion before adding the lactose aqueous solution and the physical properties of the cellulose particles O for formulation.
比较例1Comparative example 1
向由实施例1所得的固体含量为约40%的饼状产物中加入水,然后用均化混合器将该混合物制备成固体含量为15重量%的纤维素分散液。在对粒径、pH和IC进行调节后,将该分散液在与实施例1相同的条件下进行喷雾干燥。用网眼为212μm的筛网除去粗大的粒子,然后通过使其通过网眼为45μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子P。干燥前的纤维素分散液中的纤维素粒子的粒径和粒子P的物理性质如表3所示。Water was added to the cake-like product obtained in Example 1 having a solid content of about 40%, and the mixture was prepared into a cellulose dispersion having a solid content of 15% by weight using a homomixer. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1. Coarse particles were removed with a mesh of 212 μm, and then fine particles were removed by passing through a mesh of 45 μm. Thus, cellulose particles P for formulations were obtained. Table 3 shows the particle diameters of the cellulose particles in the cellulose dispersion before drying and the physical properties of the particles P.
比较例2Comparative example 2
将市售的DP切割成碎片,然后用105℃的1%盐酸水溶液在水解10分钟。将所得的酸不溶性残余物过滤,然后用水进行洗涤,得到固体浓度为约40%的微晶纤维素的饼状产物。将该饼状产物用万能混合搅拌机研磨10分钟。向其中加入水。用均化混合器将该经研磨的饼状产物和水的混合物形成固体含量为15重量%的纤维素分散液。在对粒径、pH和IC进行调节后,在与实施例1相同的条件下对该分散液进行喷雾干燥。用网眼为300μm的筛网除去粗大的粒子,然后通过使其通过网眼为106μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子Q。干燥前的纤维素分散液中的经研磨粒子的粒径和粒子Q的物理性质如表3所示。The commercially available DP was cut into pieces, and then hydrolyzed with 1% hydrochloric acid aqueous solution at 105°C for 10 minutes. The resulting acid-insoluble residue was filtered and washed with water to obtain a cake-like product of microcrystalline cellulose having a solids concentration of about 40%. The cake-like product was ground for 10 minutes with a universal mixer. Add water to it. The mixture of the ground cake product and water was formed into a cellulose dispersion having a solids content of 15% by weight with a homomixer. After adjusting the particle size, pH and IC, the dispersion was spray-dried under the same conditions as in Example 1. Coarse particles were removed by a sieve with a mesh of 300 μm, and then fine particles were removed by passing through a sieve with a mesh of 106 μm. Thus, cellulose particles Q for formulations were obtained. Table 3 shows the particle diameters of the ground particles in the cellulose dispersion before drying and the physical properties of the particles Q.
比较例3Comparative example 3
用万能混合搅拌机将比较例2所得的饼状产物研磨1小时。向其中加入水。用均化混合器将该经研磨的饼状产物和水的混合物形成固体含量为10重量%的纤维素分散液。在120MPa的压力下使该分散液通过高压破碎机三次,从而完成破碎处理。在对粒径、pH和IC进行调节后,在与实施例1相同的条件下对该分散液进行喷雾干燥,只是将给气温度变为180℃。用网眼为250μm的筛网除去粗大的粒子,然后通过使其通过网眼为75μm的筛网来除去细小的粒子。从而获得制剂用纤维素粒子R。干燥前的纤维素分散液中的经研磨粒子的粒径和粒子R的物理性质如表3所示。The cake-like product obtained in Comparative Example 2 was ground for 1 hour with a universal mixer. Add water to it. The mixture of the ground cake product and water was formed into a cellulose dispersion having a solids content of 10% by weight with a homomixer. The dispersion was passed through a high-pressure crusher three times under a pressure of 120 MPa, thereby completing the crushing process. After adjusting the particle size, pH, and IC, the dispersion was spray-dried under the same conditions as in Example 1, except that the supply air temperature was changed to 180°C. Coarse particles were removed with a mesh of 250 μm, and fine particles were removed by passing through a mesh of 75 μm. Thus, cellulose particles R for formulations were obtained. Table 3 shows the particle diameters of the ground particles in the cellulose dispersion before drying and the physical properties of the particles R.
比较例4Comparative example 4
根据JP-A 7-173050中所公开的方法,将1.5kg的微晶纤维素放入到高速搅拌造粒机(FM-VG-10型,由Powrex Co.制造)中,向其中加入1.0kg的水,然后将该混合物捏合5分钟。将所得的1公斤湿颗粒转移到Malmerizer(Q-230型,由Fuji Paudal Co.,Ltd.制造)中,然后将其以500rpm的速度转动10分钟,同时以10g/分钟的速度喷水,从而将该颗粒形成球形。此后,在热气干燥机(PV-211型,由TabaiESPEC Co.制造)中,将这些球形物在40℃下干燥一天一夜。用网眼为150μm的筛网除去粗大的粒子,然后用网眼为75μm的筛网来除去细小的粒子,从而获得制剂用纤维素粒子S。粒子S的物理性质如表4所示。According to the method disclosed in JP-A 7-173050, 1.5 kg of microcrystalline cellulose was put into a high-speed stirring granulator (FM-VG-10 type, manufactured by Powrex Co.), and 1.0 kg of of water, and knead the mixture for 5 minutes. 1 kg of the resulting wet pellets was transferred to a Malmerizer (Model Q-230, manufactured by Fuji Paudal Co., Ltd.), which was then rotated at a speed of 500 rpm for 10 minutes while spraying water at a speed of 10 g/min, thereby The particles were formed into spherical shapes. Thereafter, these spheres were dried at 40° C. for one day and one night in a hot air dryer (PV-211 type, manufactured by TabaiESPEC Co.). Coarse particles were removed with a mesh of 150 μm, and fine particles were removed with a mesh of 75 μm to obtain cellulose particles S for preparation. The physical properties of particles S are shown in Table 4.
比较例5Comparative Example 5
用与比较例4相同的方法来进行粒子的制备。用网眼为212μm的筛网除去粗大的粒子,并且用网眼为106μm的筛网来除去细小的粒子,从而获得制剂用纤维素粒子T。粒子T的物理性质如表4所示。Particles were prepared in the same manner as in Comparative Example 4. Coarse particles were removed with a mesh of 212 μm, and fine particles were removed with a mesh of 106 μm to obtain cellulose particles T for preparation. The physical properties of particles T are shown in Table 4.
比较例6Comparative example 6
用与比较例4相同的方法来进行粒子的制备,只是将加入的水增加至1.2kg。用网眼为300μm的筛网除去粗大的粒子,并且用网眼为212μm的筛网来除去细小的粒子,从而获得制剂用纤维素粒子U。粒子U的物理性质如表4所示。Preparation of particles was carried out in the same manner as in Comparative Example 4 except that the added water was increased to 1.2 kg. Coarse particles were removed with a mesh of 300 μm, and fine particles were removed with a mesh of 212 μm to obtain cellulose particles U for preparations. The physical properties of particles U are shown in Table 4.
比较例7Comparative Example 7
将市售的结晶纤维素(AVICEL(注册商标)PH-200,由FMC Co.制造)通过网眼为45μm的筛网以除去细小的粒子,从而获得粒子V。粒子V的物理性质如表4所示。Particles V were obtained by passing commercially available crystalline cellulose (AVICEL (registered trademark) PH-200, manufactured by FMC Co.) through a sieve with an opening of 45 μm to remove fine particles. The physical properties of particle V are shown in Table 4.
比较例8Comparative Example 8
将废人造丝切碎,然后用100℃的10%盐酸水溶液将其水解40分钟。将所得的酸不溶性残余物用热水通过倾析法进行洗涤,然后将其制备成固体含量为10重量%的纤维素分散液。在对粒径、pH和IC进行调节后,在与实施例1相同的条件下对该分散液进行喷雾干燥,只是将给气温度变为180℃。用网眼为75μm的筛网除去粗大的粒子,然后用网眼为45μm的筛网来除去细小的粒子,从而获得制剂用纤维素粒子W。干燥前的纤维素分散液中的经研磨粒子的粒径和粒子W的物理性质如表4所示。The waste rayon was chopped and then hydrolyzed with 10% aqueous hydrochloric acid at 100°C for 40 minutes. The resulting acid-insoluble residue was washed with hot water by decantation, and then it was prepared into a cellulose dispersion having a solid content of 10% by weight. After adjusting the particle size, pH, and IC, the dispersion was spray-dried under the same conditions as in Example 1, except that the supply air temperature was changed to 180°C. Coarse particles were removed with a mesh of 75 μm, and fine particles were removed with a mesh of 45 μm to obtain cellulose particles W for formulation. Table 4 shows the particle diameters of the ground particles and the physical properties of the particles W in the cellulose dispersion before drying.
比较例9Comparative Example 9
将市售的糖类球形核粒子(NONPAREIL(注册商标)NP101“32-42”(精制糖∶玉米淀粉=7∶3),由Freund Industrial Co.,Ltd.制造)通过网眼为420μm的筛网进行筛分以除去粗大的粒子,从而获得粒子X。粒子X的物理性质如表4所示。Commercially available sugar spherical core particles (NONPAREIL (registered trademark) NP101 "32-42" (refined sugar:corn starch=7:3), manufactured by Freund Industrial Co., Ltd.) were passed through a sieve with a mesh size of 420 μm Sieving was performed to remove coarse particles, whereby Particle X was obtained. The physical properties of particle X are shown in Table 4.
实施例16Example 16
用带有切向(tangential)底部喷雾器的旋转流化床型造粒包衣机(“MULTIPLEX”MP-01型,由Powrex Co.制造)将1.0kg得自实施例1的制剂用纤维素粒子A在如下的条件下流化20分钟:旋转盘的旋转速度:450rpm,喷雾的气压:0.16MPa,喷雾的空气流量:40l/分钟,保护气压:0.20MPa,给气温度:室温(无加热器),排气温度:室温,风量:40m3/小时。与该粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表5所示。1.0 kg of the cellulose particles for formulation obtained in Example 1 were prepared with a rotary fluidized bed type granulation coating machine ("MULTIPLEX" MP-01 type, manufactured by Powrex Co.) with a tangential bottom sprayer. A is fluidized for 20 minutes under the following conditions: rotation speed of the rotating disk: 450rpm, spray air pressure: 0.16MPa, spray air flow: 40l/min, protection air pressure: 0.20MPa, air supply temperature: room temperature (without heater) , Exhaust temperature: room temperature, air volume: 40m 3 /hour. Table 5 shows the results related to the fluidity, fragility, and adhesion of the particles to the bag filter.
实施例17Example 17
将得自实施例2的粒子B在与实施例16相同的条件下流化20分钟。与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表5所示。Particle B from Example 2 was fluidized under the same conditions as in Example 16 for 20 minutes. Table 5 shows the results related to the fluidity and friability of the particles and their attachment to the bag filter.
比较例10Comparative Example 10
将得自比较例1的粒子P在与实施例14相同的条件下流化20分钟。与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表5所示。The particles P obtained in Comparative Example 1 were fluidized under the same conditions as in Example 14 for 20 minutes. Table 5 shows the results related to the fluidity and friability of the particles and their attachment to the bag filter.
比较例11Comparative Example 11
将得自比较例7的粒子V在与实施例16相同的条件下流化20分钟。与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表5所示。Particles V obtained in Comparative Example 7 were fluidized under the same conditions as in Example 16 for 20 minutes. Table 5 shows the results related to the fluidity and friability of the particles and their attachment to the bag filter.
实施例18Example 18
除将风量变为50m3/小时外,在与实施例16相同的条件下,将1.0kg得自实施例8的制剂用纤维素粒子H流化10分钟,与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表6所示。Except that the air volume was changed to 50 m 3 /hour, under the same conditions as in Example 16, 1.0 kg of the cellulose particles H for preparation obtained in Example 8 were fluidized for 10 minutes, and the fluidity, brittleness and other characteristics of the particles were different. The results related to the attachment of the bag filter are shown in Table 6.
比较例12Comparative Example 12
在与实施例18的条件相同的条件下,将得自比较例9的粒子X流化10分钟。与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表6所示。Under the same conditions as those of Example 18, Particle X from Comparative Example 9 was fluidized for 10 minutes. The results related to the fluidity, friability of the particles and their attachment to the bag filter are shown in Table 6.
实施例19Example 19
用带有改进的武斯特氏柱的MP-01型将1.0kg得自实施例3的制剂用纤维素粒子C在如下的条件下流化20分钟:喷雾的气压:0.16MPa,喷雾的空气流量:40l/分钟,侧气压:0.20MPa,侧面的空气吐出时间:0.2秒,侧面的空气停止时间:3.0秒,给气温度:室温(无加热器),排气温度:室温,风量:30m3/小时。与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表7所示。With the MP-01 type that has improved Wuerster column, 1.0kg is obtained from the preparation cellulose particle C of embodiment 3 and fluidized 20 minutes under the following conditions: the air pressure of spraying: 0.16MPa, the air flow rate of spraying : 40l/min, side air pressure: 0.20MPa, side air discharge time: 0.2 seconds, side air stop time: 3.0 seconds, air supply temperature: room temperature (without heater), exhaust temperature: room temperature, air volume: 30m3 /Hour. The results related to the fluidity, friability of the particles and their attachment to the bag filter are shown in Table 7.
比较例13Comparative Example 13
在与实施例19相同的条件下,将1.0kg得自比较例8的粒子K流化20分钟。与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表7所示。Under the same conditions as in Example 19, 1.0 kg of Particle K obtained in Comparative Example 8 was fluidized for 20 minutes. The results related to the fluidity, friability of the particles and their attachment to the bag filter are shown in Table 7.
实施例20Example 20
在与实施例19相同的条件下,将1.0kg得自实施例13的制剂用纤维素粒子M流化20分钟。与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表8所示。Under the same conditions as in Example 19, 1.0 kg of the cellulose particles M for formulation obtained in Example 13 were fluidized for 20 minutes. The results related to the fluidity, friability of the particles and their attachment to the bag filter are shown in Table 8.
比较例14Comparative Example 14
在与实施例20相同的条件下,将1.0kg得自比较例1的粒子P流化20分钟,其中该粒子中的一部分通过从网眼为38μm的筛网通过而被除去。与粒子的流动性、脆性以及其与袋滤器的附着有关的结果如表8所示。Under the same conditions as in Example 20, 1.0 kg of the particles P obtained in Comparative Example 1 were fluidized for 20 minutes, with a part of the particles being removed by passing through a sieve having a mesh size of 38 μm. The results related to the fluidity, friability of the particles and their attachment to the bag filter are shown in Table 8.
实施例21Example 21
用带有切向底部喷雾器的MP-01型将包含3份咖啡因、2份羟丙基纤维素(L型,由Nippon Soda Co.,Ltd.制造)和95份水的活性成分以5.5g/分钟的比例制剂用在如下的条件下向0.5kg得自实施例1的制剂用纤维素粒子A进行喷雾:旋转盘转速:450rpm,喷雾的气压:0.16MPa,喷雾的空气流量:40l/分钟,保护气压:0.20MPa,给气温度:75℃,排气温度:35℃,风量:30m3/小时,直至成层于制剂用纤维素粒子上的咖啡因的量达到2重量%为止。将所得的颗粒通过网眼为177μm的筛网,计算粗粒子占该颗粒的比例。如表9所示,其证明了可以在几乎不发生聚集的情况下进行活性成分的成层。The active ingredient comprising 3 parts of caffeine, 2 parts of hydroxypropyl cellulose (L type, manufactured by Nippon Soda Co., Ltd.) and 95 parts of water was dissolved in 5.5 g with a MP-01 type sprayer with a tangential bottom sprayer. Ratio per minute The preparation was sprayed to 0.5 kg of the cellulose particles A obtained from Example 1 for the preparation under the following conditions: rotating disk speed: 450 rpm, spray air pressure: 0.16 MPa, spray air flow: 40 l/min , Protection air pressure: 0.20MPa, air supply temperature: 75°C, exhaust temperature: 35°C, air volume: 30m 3 /hour, until the amount of caffeine layered on the cellulose particles for preparation reaches 2% by weight. The obtained granules were passed through a sieve with an opening of 177 μm, and the ratio of coarse particles to the granules was calculated. As shown in Table 9, it was demonstrated that layering of the active ingredient can be performed with little aggregation.
比较例15Comparative Example 15
在与实施例21相同的条件下,将咖啡因成层于0.5kg得自比较例4的粒子S上。如表9所示,发现与实施例1中的制剂用纤维素粒子A相比,其更容易发生聚集。Caffeine was layered on 0.5 kg of the particles S obtained in Comparative Example 4 under the same conditions as in Example 21. As shown in Table 9, it was found that aggregation occurred more easily than the cellulose particles A for formulation in Example 1.
比较例16Comparative Example 16
用带有切向底部喷雾器的MP-01型将与实施例21的活性成分溶液类似的活性成分溶液以4.5g/分钟的比例向0.5kg得自比较例7的粒子V(已通过网眼为177μm的筛网除去了粗大的粒子,并通过使其通过网眼为75μm的筛网而除去了细小粒子)在如下的条件下进行喷雾:旋转盘转速:280rpm,喷雾的气压:0.13MPa,喷雾的空气流量:30l/分钟,保护气压:0.10MPa,给气温度:75℃,排气温度:36℃,风量:30m3/hr,直至成层于粒子上的咖啡因的量达到2重量%为止。如表9所示,发现与实施例1中的制剂用纤维素粒子A相比,其更容易发生聚集。An active ingredient solution similar to that of Example 21 was injected into 0.5 kg of particles V from Comparative Example 7 (passed through a mesh of 177 μm) at a rate of 4.5 g/min with a MP-01 type tangential bottom sprayer. Coarse particles are removed by a sieve, and fine particles are removed by making it pass through a sieve with a mesh size of 75 μm) Spraying is carried out under the following conditions: rotating disk speed: 280rpm, spray air pressure: 0.13MPa, spray air Flow rate: 30 l/min, protective air pressure: 0.10 MPa, air supply temperature: 75°C, exhaust temperature: 36°C, air volume: 30m 3 /hr, until the amount of caffeine layered on the particles reaches 2% by weight. As shown in Table 9, it was found that aggregation occurred more easily than the cellulose particles A for formulation in Example 1.
实施例22Example 22
在与实施例21相同的条件下,将咖啡因成层于0.5kg得自实施例2的纤维素粒子B上,直至成层于纤维素粒子上的咖啡因的量达到2重量%为止。将所得的颗粒通过网眼为212μm的筛网,计算粗大粒子占该颗粒的比例。如表10所示,其证明了可以在几乎不发生聚集的情况下进行活性成分的成层。Under the same conditions as in Example 21, caffeine was layered on 0.5 kg of the cellulose particles B obtained in Example 2 until the amount of caffeine layered on the cellulose particles reached 2% by weight. The obtained particles were passed through a sieve with a mesh size of 212 μm, and the ratio of coarse particles to the particles was calculated. As shown in Table 10, it was demonstrated that layering of the active ingredient can be performed with little aggregation.
比较例17Comparative Example 17
在与实施例22相同的条件下,将咖啡因成层于0.5kg得自比较例5的粒子T上,直至成层于粒子上的咖啡因的量达到2重量%为止。如表10所示,发现与实施例2中的制剂用纤维素粒子B相比,其更容易发生聚集。Under the same conditions as in Example 22, caffeine was layered on 0.5 kg of the particles T obtained in Comparative Example 5 until the amount of caffeine layered on the particles reached 2% by weight. As shown in Table 10, it was found that aggregation occurred more easily than the cellulose particles B for formulation in Example 2.
实施例23Example 23
用带有切向底部喷雾器的MP-01型将包含4份咖啡因、5份羟丙基纤维素(SL型,由Nippon Soda Co.,Ltd.制造)和91份水的活性成分以5.5g/分钟的比例制剂用在如下的条件下向0.8kg得自实施例1的制剂用纤维素粒子A喷雾:旋转盘转速:450rpm,喷雾的气压:0.20MPa,喷雾的空气流量:40l/分钟,保护气压:0.20MPa,给气温度:80℃,排气温度:37℃,风量:30m3/小时,直至成层于制剂用纤维素粒子上的咖啡因的量达到10重量%为止。将所得的颗粒通过网眼为212μm的筛网,计算粗粒子占该颗粒的比例。如表11所示,其证明了可以在仅发生很少聚集的情况下进行活性成分的成层。The active ingredient comprising 4 parts of caffeine, 5 parts of hydroxypropylcellulose (SL type, manufactured by Nippon Soda Co., Ltd.) and 91 parts of water was sprayed in 5.5 g with a MP-01 type with a tangential bottom sprayer. The ratio formulation per minute was used to spray 0.8 kg of the cellulose particles A obtained from Example 1 under the following conditions: rotating disk speed: 450 rpm, spray air pressure: 0.20 MPa, spray air flow: 40 l/min, Protective air pressure: 0.20 MPa, air supply temperature: 80°C, exhaust temperature: 37°C, air volume: 30m 3 /hour, until the amount of caffeine layered on the cellulose particles for preparation reaches 10% by weight. The obtained granules were passed through a sieve with a mesh size of 212 μm, and the ratio of coarse particles to the granules was calculated. As shown in Table 11, it was demonstrated that layering of the active ingredient can be performed with only little aggregation occurring.
比较例18Comparative Example 18
在与实施例23相同的条件下,将咖啡因成层于0.8kg得自比较例4的粒子S上。如表11所示,发现与实施例1的制剂用纤维素粒子A相比,其更容易发生聚集。Under the same conditions as in Example 23, caffeine was layered on 0.8 kg of particles S from Comparative Example 4. As shown in Table 11, compared with the cellulose particle A for formulations of Example 1, aggregation was found to occur more easily.
实施例24Example 24
在与实施例23相同的条件下,将咖啡因成层于0.8kg得自实施例2的纤维素粒子B上直至成层于该纤维素粒子上的咖啡因的量达到10重量%为止。将所得的颗粒通过网眼为250μm的筛网,计算粗粒子占该颗粒的比例。如表12所示,其证明可以在几乎不发生聚集的情况下进行活性成分的成层。Under the same conditions as in Example 23, caffeine was layered on 0.8 kg of the cellulose particles B obtained in Example 2 until the amount of caffeine layered on the cellulose particles reached 10% by weight. The obtained granules were passed through a sieve with a mesh size of 250 μm, and the ratio of coarse particles to the granules was calculated. As shown in Table 12, it was demonstrated that layering of the active ingredient can be performed with little aggregation.
比较例19Comparative Example 19
在与实施例23相同的条件下,将咖啡因成层于0.8kg得自比较例5的粒子T上,直至成层于粒子上的咖啡因的量达到10重量%为止。如表12所示,发现与实施例2中的制剂用纤维素粒子B相比,其更容易发生聚集。Under the same conditions as in Example 23, caffeine was layered on 0.8 kg of the particles T obtained in Comparative Example 5 until the amount of caffeine layered on the particles reached 10% by weight. As shown in Table 12, it was found that aggregation occurred more easily than the cellulose particles B for formulation in Example 2.
实施例25Example 25
用带有切向底部喷雾器的MP-01型,将包含4份咖啡因、5份羟丙基纤维素(SL型,由Nippon Soda Co.,Ltd.制造)和91份水的活性成分以9.0g/分钟的比例在如下的条件下向1.0kg得自比较例7的粒子G(已通过网眼为212μm的筛网除去了细小粒子)喷雾:旋转盘转速:450rpm,喷雾的气压:0.20MPa,喷雾的空气流量:40l/分钟,保护气压:0.20MPa,给气温度:80℃,排气温度:36℃,风量:40m3/小时,直至成层于该制剂用纤维素粒子上的咖啡因的量达到10重量%为止。将所得的颗粒通过网眼为350μm的筛网,计算粗大粒子占该颗粒的比例。如表13所示,证明可以在仅发生很少聚集的情况下来进行活性成分的成层。With MP-01 type with tangential bottom sprayer, the active ingredient comprising 4 parts of caffeine, 5 parts of hydroxypropyl cellulose (SL type, manufactured by Nippon Soda Co., Ltd.) and 91 parts of water was mixed at 9.0 The ratio of g/min is sprayed to 1.0kg from the particle G of Comparative Example 7 (a sieve with a mesh size of 212 μm has removed fine particles) under the following conditions: rotating disk speed: 450rpm, spray air pressure: 0.20MPa, Spray air flow rate: 40l/min, protective air pressure: 0.20MPa, air supply temperature: 80°C, exhaust temperature: 36°C, air volume: 40m 3 /hour, until the caffeine layered on the cellulose particles for the preparation up to 10% by weight. The obtained particles were passed through a sieve with a mesh size of 350 μm, and the ratio of coarse particles to the particles was calculated. As shown in Table 13, it was demonstrated that layering of the active ingredient can be performed with only little aggregation occurring.
比较例20Comparative Example 20
在与实施例25相同的条件下,将咖啡因成层于1.0kg得自比较例6的粒子U上。如表13所示,发现与实施例7中的制剂用纤维素粒子G相比,其更容易发生聚集。Caffeine was layered on 1.0 kg of particles U from Comparative Example 6 under the same conditions as in Example 25. As shown in Table 13, it was found that aggregation occurred more easily than the cellulose particles G for formulation in Example 7.
实施例26Example 26
用带有改进的武斯特氏柱的MP-01型,将包含10份维生素B2、2份羟丙基纤维素(SL型,得自Nippon Soda Co.,Ltd制造)和88份水的活性成分的分散液以5.0g/分钟的比例制剂用在如下的条件下向0.8kg得自实施例13的制剂用纤维素粒子M喷雾:喷雾的气压:0.20MPa,喷雾的空气流量:40l/分钟,侧面的气压:0.20MPa,侧面空气吐出时间:0.2秒,侧面的空气停止时间:3.0秒,给气温度:75℃,排气温度:37℃,风量:35m3/小时,直至成层于该制剂用纤维素粒子上的维生素B2的量达到2重量%为止。将所得的颗粒通过网眼为38μm的筛网,计算粗大粒子占该颗粒的比例。如表14所示,证实可以在仅发生很少聚集的情况下来进行活性成分的成层。Using an MP-01 type with a modified Wuster column, 10 parts of vitamin B 2 , 2 parts of hydroxypropylcellulose (SL type, manufactured by Nippon Soda Co., Ltd.) and 88 parts of water were prepared. The dispersion of the active ingredient was sprayed at a rate of 5.0 g/min for the preparation of 0.8 kg of the cellulose particles M obtained from Example 13 under the following conditions: the air pressure of the spray: 0.20 MPa, the air flow rate of the spray: 40 l/ Minutes, side air pressure: 0.20MPa, side air discharge time: 0.2 seconds, side air stop time: 3.0 seconds, air supply temperature: 75°C, exhaust temperature: 37°C, air volume: 35m 3 /hour, until layered The amount of vitamin B2 on the cellulose particles for the formulation was up to 2% by weight. The obtained particles were passed through a sieve with a mesh size of 38 μm, and the ratio of coarse particles to the particles was calculated. As shown in Table 14, it was confirmed that the layering of the active ingredient can be performed with only little aggregation occurring.
比较例21Comparative Example 21
用带有改进的武斯特氏柱的MP-01型,除将喷雾的气压、喷雾的空气流速和侧面的气压分别变为0.16MPa、30l/分钟和0.18Mpa以外,在与实施例21相同的条件下将维生素B2成层于0.8kg得自比较例1的粒子P(已通过用网眼为38μm的筛网进行筛分从而除去了一部分粒子)上。如表14所示,发现与实施例13的制剂用纤维素粒子M相比,其更容易发生聚集。With the MP-01 type with the improved Wuster column, except that the air pressure of the spray, the air flow rate of the spray and the air pressure of the side become 0.16MPa, 30l/min and 0.18Mpa respectively, in the same manner as in Example 21 Vitamin B 2 was layered on 0.8 kg of the particles P obtained in Comparative Example 1 (part of the particles had been removed by sieving with a sieve having a mesh size of 38 μm) under the condition of . As shown in Table 14, it was found that aggregation occurred more easily than the cellulose particles M for formulations of Example 13.
实施例27Example 27
将活性成分的成层在与实施例21相同的条件下进行两次,将所得的颗粒通过网眼为177μm的筛网以除去一部分。用带有切向底部喷雾器的MP-01型,将包含38.1份乙基纤维素水分散液、2.9份甘油三乙酸酯、5.7份D-甘露醇和53.3份水的包衣液(固体成分重量比/乙基纤维素水分散液∶甘油三乙酸酯∶D-甘露醇=1.0∶0.25∶0.50)在如下的条件下喷雾到0.7kg上面所制备的颗粒上:旋转盘转速:450rpm,喷雾的气压:0.18MPa,喷雾的空气流量:40l/分钟,保护气压:0.20MPa,给气温度:70℃,排气温度:36℃,风量:40m3/小时,包衣液给料速度:7g/分钟,直至包衣于该颗粒上的固体量达到25.0重量%为止。将所得的包衣颗粒通过网眼为212μm的筛网,计算粗大粒子占该包衣颗粒的比例。如表15所示,证明可以在仅发生很少聚集的情况下获得包衣颗粒。将所得的颗粒在80℃下用热风干燥器热处理1小时,从而完成膜的制备,并且其后由10名专门小组的成员来对其进行苦味分析。如表15所示,发现即使在30秒后也没有苦味,因此证明其掩盖了苦味。Layering of the active ingredient was performed twice under the same conditions as in Example 21, and the resulting granules were passed through a sieve with a mesh size of 177 μm to remove a part. Using the MP-01 type with tangential bottom sprayer, the coating liquid (solid content weight Ratio/ethyl cellulose aqueous dispersion: triacetin: D-mannitol=1.0: 0.25: 0.50) is sprayed on the granule prepared above 0.7kg under the following conditions: rotating disk speed: 450rpm, spray Air pressure: 0.18MPa, spray air flow rate: 40l/min, protective air pressure: 0.20MPa, air supply temperature: 70°C, exhaust temperature: 36°C, air volume: 40m 3 /hour, coating liquid feeding rate: 7g /min until the amount of solids coated on the granules reaches 25.0% by weight. The obtained coated granules were passed through a sieve with a mesh size of 212 μm, and the ratio of coarse particles to the coated granules was calculated. As shown in Table 15, it was demonstrated that coated particles could be obtained with only little aggregation occurring. The resulting pellets were heat-treated at 80° C. for 1 hour with a hot-air drier to complete film preparation, and thereafter were subjected to bitterness analysis by 10 panelists. As shown in Table 15, no bitterness was found even after 30 seconds, thus proving that it masks the bitterness.
比较例22Comparative Example 22
在与比较例16相同的条件下将活性成分的成层进行两次。将所得的颗粒通过网眼为177μm的筛网以除去一部分颗粒,然后将其再通过网眼为75μm的筛网以除去被磨碎了的细小粒子。用带有切向底部喷雾器的MP-01型,将与实施例18相同的包衣液在如下的条件下喷雾到0.7kg上面所准备的颗粒上:旋转盘转速:320rpm,喷雾的气压:0.13MPa,喷雾的空气流量:30l/分钟,保护气压:0.10MPa,给气温度:70℃,排气温度:37℃,风量:40m3/小时,包衣液给料速度:6g/分钟,直至包衣于该颗粒上的固体量达到25.0重量%为止。将所得的包衣颗粒通过网眼为212μm的筛网,然后再使其通过网眼为75μm的筛网以除去被破碎了的细小粒子。计算粗大粒子占该包衣颗粒的比例。如表15所示,发现与实施例27所得的颗粒相比,其更容易发生聚集。将所得的颗粒进行与实施例27的热成膜处理相同的处理。将所得的颗粒进行与实施例27相同的苦味分析。如表15所示,在30秒后发现出现苦味,从而证明其不能掩盖苦味。Layering of the active ingredient was performed twice under the same conditions as in Comparative Example 16. The resulting granules were passed through a sieve with a mesh size of 177 µm to remove a part of the particles, and then passed through a sieve with a mesh size of 75 µm to remove pulverized fine particles. With the MP-01 type that has tangential bottom sprayer, the coating solution identical with embodiment 18 is sprayed on the granule that prepares above 0.7kg under following conditions: rotating disk speed: 320rpm, the air pressure of spraying: 0.13 MPa, spray air flow rate: 30l/min, protective air pressure: 0.10MPa, air supply temperature: 70°C, exhaust temperature: 37°C, air volume: 40m 3 /hour, coating solution feeding speed: 6g/min, until The amount of solids coated on the granules was up to 25.0% by weight. The obtained coated granules were passed through a sieve with a mesh size of 212 µm, and then passed through a mesh with a mesh size of 75 µm to remove broken fine particles. Calculate the proportion of coarse particles to the coated granules. As shown in Table 15, it was found that aggregation occurred more easily than the particles obtained in Example 27. The resulting pellets were subjected to the same treatment as in Example 27 for thermal film formation. The resulting granules were subjected to the same bitterness analysis as in Example 27. As shown in Table 15, bitterness was found to develop after 30 seconds, proving that it could not mask the bitterness.
实施例28Example 28
将50份得自实施例27的包衣颗粒、17份D-甘露醇、30份微晶纤维素(Ceolus KG-802,由Asahi Chemical Industry Co.,Ltd.制造)、以及3份交联羧甲基纤维素钠在塑料袋中混合3分钟,然后将0.5g该样品放入到压缩机(TESTSTAND 1321DW-CREEP型,由AIKOHEngineering Co.,Ltd.制造)的臼中,用底面积为1cm2的平面杵以1cm/分钟的速度进行压缩,直至压力达到10MPa为止,从而获得包含颗粒的片剂。由10名专门小组的成员来对其进行苦味分析。在口中的溶解良好,并且即使在30秒后几乎也没有发现苦味。因此,其证实了苦味被掩盖。50 parts of coated granules obtained in Example 27, 17 parts of D-mannitol, 30 parts of microcrystalline cellulose (Ceolus KG-802, manufactured by Asahi Chemical Industry Co., Ltd.), and 3 parts of cross-linked carboxyl Sodium methylcellulose was mixed in a plastic bag for 3 minutes, and then 0.5 g of the sample was put into the mortar of a compressor (TESTSTAND 1321DW-CREEP type, manufactured by AIKOHEngineering Co., Ltd.) with a bottom area of 1 cm Compress with a flat pestle at a speed of 1 cm/min until the pressure reaches 10 MPa to obtain tablets containing granules. Bitterness analysis was performed by 10 panelists. Dissolution in the mouth was good, and bitterness was hardly detected even after 30 seconds. Therefore, it was confirmed that the bitterness was masked.
比较例23Comparative Example 23
用与实施例28相同的方法来制备包含颗粒的片剂,只是使用50份得自比较例22的包衣颗粒。将所得片剂进行与实施例28相同的分析。结果是,虽然片剂在口中的溶解良好,但是在服用后立即发现苦味,所以证明其不能掩盖苦味。Tablets containing granules were prepared in the same manner as in Example 28 except that 50 parts of the coated granules obtained in Comparative Example 22 were used. The resulting tablet was subjected to the same analysis as in Example 28. As a result, although the tablet dissolved well in the mouth, a bitter taste was found immediately after taking it, so it was proved that it could not mask the bitter taste.
实施例29Example 29
用带有切向底部喷雾器的MP-01型,将包含10份维生素B2、2份羟丙基纤维素(SL型,由Nippon Soda Co.,Ltd.制造)和88份水的活性成分的分散液以5.0g/分钟在如下的条件下向1.0kg得自实施例1的制剂用纤维素粒子A进行喷雾:旋转盘转速:450rpm,喷雾的气压:0.16MPa,喷雾的空气流量:40l/分钟,保护气压:0.20MPa,给气温度:75℃,排气温度:35℃,直至成层于该制剂用纤维素粒子上的维生素B2的量达到2重量%为止。将所得的颗粒通过网眼为177μm的筛网以除去一部分颗粒。随后,用带有切向底部喷雾器的MP-01型,将包含38.1份乙基纤维素水分散液、2.9份枸橼酸三乙酯、1.4份羟丙基甲基纤维素(TC-5E,由Shin-Etsu Chemical Co.,Ltd.制造)和59.6份水的包衣液(固体成分重量比/乙基纤维素水分散液∶枸橼酸三乙酯∶TC-5E=1.0∶0.25∶0.125)在如下的条件下喷雾到0.7kg上面所制备的粒子上:旋转盘转速:450rpm,喷雾的气压:0.18MPa,喷雾的空气流量:40l/分钟,保护气压:0.20MPa,给气温度:70℃,排气温度:36℃,风量:40m3/小时,包衣液给料速度:7g/分钟,直至包衣于该颗粒上的固体量达到20.0重量%为止。将所得的包衣颗粒通过网眼为212μm的筛网以除去粗大的粒子。将所得的颗粒在80℃下用热风干燥器热处理1小时,从而完成膜的制备,然后根据第13版日本药典中的第二溶解物质试验方法(试验液:900ml第13版日本药典通用试验方法的崩解试验方法中的第一种液体,浆的转速:100rpm,用自动溶解试验机DT-610型,由JASCO Co.制造)对其进行试验。通过吸光光度法测定4小时后维生素B2的溶解率时,发现3次的平均值为39%。Using MP-01 type with tangential bottom sprayer, the active ingredient containing 10 parts of vitamin B 2 , 2 parts of hydroxypropyl cellulose (SL type, manufactured by Nippon Soda Co., Ltd.) and 88 parts of water The dispersion was sprayed to 1.0 kg of the cellulose particles A obtained from Example 1 under the following conditions at 5.0 g/min: rotating disk speed: 450 rpm, spray air pressure: 0.16 MPa, spray air flow: 40 l/ Minutes, protective air pressure: 0.20MPa, air supply temperature: 75°C, exhaust temperature: 35°C, until the amount of vitamin B2 layered on the cellulose particles for the preparation reaches 2% by weight. The obtained particles were passed through a sieve having an opening of 177 μm to remove a part of the particles. Subsequently, using the MP-01 type with a tangential bottom sprayer, the aqueous dispersion containing 38.1 parts of ethyl cellulose, 2.9 parts of triethyl citrate, 1.4 parts of hydroxypropyl methylcellulose (TC-5E, Coating liquid (manufactured by Shin-Etsu Chemical Co., Ltd.) and 59.6 parts of water (solid content weight ratio/ethylcellulose aqueous dispersion: triethyl citrate: TC-5E = 1.0: 0.25: 0.125 ) is sprayed onto 0.7kg of the particles prepared above under the following conditions: rotating disk speed: 450rpm, spray air pressure: 0.18MPa, spray air flow: 40l/min, protection air pressure: 0.20MPa, air supply temperature: 70 °C, exhaust temperature: 36 °C, air volume: 40m 3 /hour, feeding speed of coating liquid: 7g/min, until the amount of solids coated on the granules reaches 20.0% by weight. The obtained coated granules were passed through a sieve with an opening of 212 μm to remove coarse particles. The obtained particles were heat-treated with a hot air drier for 1 hour at 80° C. to complete the preparation of the film, and then according to the second dissolved substance test method in the 13th edition of the Japanese Pharmacopoeia (test solution: 900 ml of the 13th edition of the Japanese Pharmacopoeia General Test Method The first liquid in the disintegration test method, the rotation speed of the slurry: 100 rpm, was tested with an automatic dissolution tester DT-610 type, manufactured by JASCO Co.). When the dissolution rate of vitamin B2 was measured by absorptiometry after 4 hours, the average value of 3 times was found to be 39%.
比较例24Comparative Example 24
用带有切向底部喷雾器的MP-01型,将与实施例24相同的成层活性成分分散液以5g/分钟的比例在如下的条件下向1.0kg得自比较例7的粒子V(已通过网眼为177μm的筛网除去粗大的粒子,并且还通过网眼为75μm的筛网除去细小粒子)进行喷雾:旋转盘转速:280rpm,喷雾的气压:0.13MPa,喷雾的空气流量:30l/分钟,保护气压:0.10MPa,给气温度:75℃,排气温度:36℃,风量:30m3/小时,直至包衣于制剂用纤维素粒子上的维生素B2量达到2重量%为止。将所得的包衣颗粒通过网眼为177μm的筛网以除去一部分颗粒,然后再使其通过网眼为75μm的筛网以除去被粉碎了的细小粒子。随后,用带有切向底部喷雾器的MP-01型,将与实施例29相同的包衣液在如下的条件下喷雾到0.7kg上面所制备的颗粒上:旋转盘转速:320rpm,喷雾的气压:0.13MPa,喷雾的空气流量:30l/分钟,保护气压:0.10MPa,给气温度:70℃,排气温度:37℃,风量:40m3/小时,包衣液给料速度:5.5g/分钟,直至包衣于该颗粒上的固体量达到20.0重量%为止。将所得的包衣颗粒通过网眼为212μm的筛网以除去粗大的粒子,然后再使其通过网眼为75μm的筛网以除去被粉碎了的细小粒子。在用与实施例24相同的热处理对其进行处理后,进行物质溶解试验。结果,通过吸光光度法测定4小时后维生素B2的溶解率时,发现3次的平均值为82%。发现与实施例29中的包衣颗粒相比,虽然在各种情况下包衣的数量相同,但是本例中溶出没有受到控制。With the MP-01 type that has tangential bottom sprayer, with embodiment 24 same layering active ingredient dispersion solution is obtained from the particle V of comparative example 7 under the following conditions to 1.0kg with the ratio of 5g/min Be that the sieve of 177 μm is removed coarse particle by mesh, and also be that the sieve of 75 μm removes fine particle) carry out spraying by mesh: rotating disk speed: 280rpm, the air pressure of spray: 0.13MPa, the air flow rate of spray: 30l/min, Protective air pressure: 0.10MPa, air supply temperature: 75°C, exhaust temperature: 36°C, air volume: 30m 3 /hour, until the amount of vitamin B 2 coated on the cellulose particles for preparation reaches 2% by weight. The obtained coated granules were passed through a sieve with a mesh of 177 µm to remove a part of the particles, and then passed through a sieve with a mesh of 75 µm to remove pulverized fine particles. Subsequently, with the MP-01 type that has tangential bottom sprayer, the coating solution identical with embodiment 29 is sprayed on the granule prepared above 0.7kg under the following conditions: rotating disk speed: 320rpm, the air pressure of spraying : 0.13MPa, spray air flow rate: 30l/min, protective air pressure: 0.10MPa, air supply temperature: 70°C, exhaust temperature: 37°C, air volume: 40m 3 /hour, coating liquid feeding rate: 5.5g/ Minutes until the amount of solids coated on the granules reaches 20.0% by weight. The obtained coated granules were passed through a sieve with a mesh of 212 μm to remove coarse particles, and then passed through a sieve with a mesh of 75 μm to remove pulverized fine particles. After it was treated with the same heat treatment as in Example 24, a substance dissolution test was carried out. As a result, when the dissolution rate of vitamin B2 after 4 hours was measured by absorptiometry, the average value of three times was found to be 82%. It was found that compared to the coated granules in Example 29, although the amount of coating was the same in each case, dissolution was not controlled in this case.
表1
表2
表3
表4
表5
表6
表7
表8
表9
表10
表11
表12
表13
表14
表15
工业实用性Industrial Applicability
本发明的制剂用纤维素粒子具有适宜的敲击堆密度、适宜的形状系数、高长宽比、适宜的水蒸汽吸收和适宜的粒子强度,因此十分适宜用作制剂用粒子,特别适宜用作被活性成分所包覆的核粒子。The cellulose particles for preparations of the present invention have suitable tapping bulk density, suitable shape factor, high aspect ratio, suitable water vapor absorption and suitable particle strength, so they are very suitable for use as particles for preparations, especially suitable for active Core particles coated with ingredients.
Claims (11)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP338243/2000 | 2000-11-06 | ||
| JP2000338243 | 2000-11-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1473054A CN1473054A (en) | 2004-02-04 |
| CN1222318C true CN1222318C (en) | 2005-10-12 |
Family
ID=18813481
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB018184219A Expired - Fee Related CN1222318C (en) | 2000-11-06 | 2001-11-06 | Cellulosic particle for pharmaceutical preparation |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20040043964A1 (en) |
| EP (1) | EP1338288B1 (en) |
| JP (1) | JP4062436B2 (en) |
| KR (1) | KR100526285B1 (en) |
| CN (1) | CN1222318C (en) |
| AT (1) | ATE327770T1 (en) |
| AU (2) | AU2002211018B2 (en) |
| BR (1) | BR0115058A (en) |
| CA (1) | CA2427991C (en) |
| DE (1) | DE60120211T2 (en) |
| TW (1) | TWI290471B (en) |
| WO (1) | WO2002036168A1 (en) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI317740B (en) | 2003-05-30 | 2009-12-01 | Asahi Kasei Chemicals Corp | Cellulose powder |
| CN100402585C (en) | 2004-01-30 | 2008-07-16 | 旭化成化学株式会社 | Porous cellulose aggregate and composition molded article comprising the same |
| EP1873196B1 (en) * | 2005-04-22 | 2016-04-13 | Asahi Kasei Chemicals Corporation | Porous cellulose aggregate and molding composition thereof |
| US20080013047A1 (en) * | 2006-06-30 | 2008-01-17 | Novavision, Inc. | Diagnostic and Therapeutic System for Eccentric Viewing |
| CN101489536B (en) * | 2006-07-19 | 2011-11-16 | 旭化成化学株式会社 | Process for producing spherical elementary granule containing readily water-soluble drug |
| JP5271081B2 (en) * | 2006-07-26 | 2013-08-21 | 旭化成ケミカルズ株式会社 | Spherical granule and method for producing the same |
| US20080279764A1 (en) * | 2007-03-09 | 2008-11-13 | Anthony Manganaro | Method and composition for treating cancer |
| JP5461179B2 (en) * | 2007-06-06 | 2014-04-02 | 旭化成ケミカルズ株式会社 | Cellulosic micronucleus particles and method for producing the same |
| EP2207533B1 (en) * | 2007-10-10 | 2021-01-06 | Avantor Performance Materials, LLC | Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof |
| US20100055180A1 (en) * | 2007-10-10 | 2010-03-04 | Mallinckrodt Baker, Inc. | Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof |
| JP2009155215A (en) * | 2007-12-25 | 2009-07-16 | Freunt Ind Co Ltd | Spherical grain, method for producing the same, and method for producing controlled release preparation |
| JP2009263303A (en) * | 2008-04-28 | 2009-11-12 | Freunt Ind Co Ltd | Spherical granule and its manufacturing method |
| JP5439366B2 (en) * | 2008-05-21 | 2014-03-12 | 旭化成ケミカルズ株式会社 | Cellulose powder excellent in segregation preventing effect and composition thereof |
| EP2308483A4 (en) | 2008-07-01 | 2014-09-10 | Sawai Seiyaku Kk | Process for production of spherical microparticles comprising tamsulosin hydrochloride |
| US20110288146A1 (en) * | 2008-11-19 | 2011-11-24 | Nandu Deorkar | Directly compressible granular microcrystalline cellulose based, excipient, manufacturing process and use thereof |
| CN102482360A (en) | 2009-10-22 | 2012-05-30 | 旭化成化学株式会社 | Methacrylic resin, molded product thereof, and method for producing methacrylic resin |
| JP2011207851A (en) * | 2010-03-30 | 2011-10-20 | Asahi Kasei Chemicals Corp | Swelling spherical core |
| UA111162C2 (en) | 2010-08-04 | 2016-04-11 | Флекшен Терап'Ютікс, Інк. | INJECTION COMPOSITION OF TRIAMCINOLONE ACETONIDE FOR TREATMENT OF PAIN |
| EP2739287B1 (en) * | 2011-08-04 | 2017-07-05 | Flexion Therapeutics, Inc. | Corticosteroids for the treatment of joint pain |
| KR20160094987A (en) * | 2013-12-04 | 2016-08-10 | 다우 글로벌 테크놀로지스 엘엘씨 | Process for preparing a mixture of a cellulose derivative and a liquid diluent |
| US10016367B2 (en) * | 2014-08-12 | 2018-07-10 | Asahi Kasei Kabushiki Kaisha | Cellulose micropowder |
| JP5877889B2 (en) * | 2014-11-07 | 2016-03-08 | 旭化成ケミカルズ株式会社 | Swellable spherical core |
| SG11201804530TA (en) * | 2015-11-30 | 2018-06-28 | Growth Partners Limited | Agent for decreasing fluidity of solid-liquid mixture, and method for producing low-fluidity mixture |
| JP6366794B2 (en) * | 2016-07-28 | 2018-08-01 | 大原薬品工業株式会社 | Orally disintegrating tablets with improved chemical stability and dosage |
| GB201715387D0 (en) * | 2017-09-22 | 2017-11-08 | Cambridge Entpr Ltd | Treatment of polymer particles |
| KR102784384B1 (en) * | 2018-07-27 | 2025-03-21 | 키에시 파르마슈티시 엣스. 피. 에이. | Novel carrier particles for dry powder formulations for inhalation |
| JP7199871B2 (en) * | 2018-08-10 | 2023-01-06 | 日揮触媒化成株式会社 | POROUS CELLULOSE PARTICLES, MANUFACTURING METHOD THEREOF, AND CLEANING COSMETIC |
| JP7265331B2 (en) * | 2018-09-28 | 2023-04-26 | 日揮触媒化成株式会社 | Porous cellulose particles and cosmetics |
| JP6751491B1 (en) * | 2018-12-27 | 2020-09-02 | 旭化成株式会社 | Cellulose powder, its use and tablets |
| JP7149885B2 (en) * | 2019-03-22 | 2022-10-07 | 株式会社ダイセル | Cellulose derivative particles, cosmetic composition, and method for producing cellulose derivative particles |
| WO2020218518A1 (en) * | 2019-04-25 | 2020-10-29 | 富士製薬工業株式会社 | Pharmaceutical preparation and method for producing same |
| PL3993646T3 (en) | 2019-07-05 | 2023-12-27 | Swedish Match North Europe Ab | An oral pouched nicotine product including a filling material comprising nicotine-containing particles |
| US20220400735A1 (en) * | 2019-11-20 | 2022-12-22 | Swedish Match North Europe Ab | An oral pouched nicotine product including a filling material comprising nicotine particles |
| JP2021095470A (en) * | 2019-12-16 | 2021-06-24 | 王子ホールディングス株式会社 | Powdery cellulose |
| CN113480669B (en) * | 2021-07-13 | 2022-08-12 | 安徽山河药用辅料股份有限公司 | Preparation method of low-bulk-density croscarmellose sodium |
| JP2024110729A (en) * | 2023-02-03 | 2024-08-16 | 富士フイルムビジネスイノベーション株式会社 | Cellulose particles |
| JP2024110728A (en) * | 2023-02-03 | 2024-08-16 | 富士フイルムビジネスイノベーション株式会社 | Cellulose particles |
| CN117686671B (en) * | 2023-12-11 | 2024-09-13 | 国药集团容生制药有限公司 | Method for optimizing dissolution curve and in-vivo bioequivalence of Engliflozin tablet |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU508480B2 (en) * | 1977-04-13 | 1980-03-20 | Asahi Kasei Kogyo Kabushiki Kaisha | Microcrystalline cellulose excipient and pharmaceutical composition containing thesame |
| JP2976116B2 (en) * | 1989-09-27 | 1999-11-10 | 旭化成工業株式会社 | Method for producing spherical cellulose particles |
| DE69111287T2 (en) * | 1990-04-18 | 1995-12-21 | Asahi Chemical Ind | Spherical nuclei, spherical granules and processes for their production. |
| US5322702A (en) * | 1992-06-15 | 1994-06-21 | Fmc Corporation | Microgranular protein opacifying material |
| US5417984A (en) * | 1992-12-14 | 1995-05-23 | Biocontrol, Inc. | Low crystallinity cellulose excipients |
| AU6786001A (en) * | 2000-07-05 | 2002-01-14 | Asahi Chemical Ind | Cellulose powder |
-
2001
- 2001-11-06 JP JP2002538977A patent/JP4062436B2/en not_active Expired - Lifetime
- 2001-11-06 CN CNB018184219A patent/CN1222318C/en not_active Expired - Fee Related
- 2001-11-06 CA CA002427991A patent/CA2427991C/en not_active Expired - Fee Related
- 2001-11-06 AT AT01979030T patent/ATE327770T1/en not_active IP Right Cessation
- 2001-11-06 US US10/415,979 patent/US20040043964A1/en not_active Abandoned
- 2001-11-06 EP EP01979030A patent/EP1338288B1/en not_active Expired - Lifetime
- 2001-11-06 WO PCT/JP2001/009691 patent/WO2002036168A1/en not_active Ceased
- 2001-11-06 DE DE60120211T patent/DE60120211T2/en not_active Expired - Lifetime
- 2001-11-06 KR KR10-2003-7006103A patent/KR100526285B1/en not_active Expired - Fee Related
- 2001-11-06 BR BR0115058-8A patent/BR0115058A/en not_active Application Discontinuation
- 2001-11-06 TW TW090127553A patent/TWI290471B/en not_active IP Right Cessation
- 2001-11-06 AU AU2002211018A patent/AU2002211018B2/en not_active Ceased
- 2001-11-06 AU AU1101802A patent/AU1101802A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1338288B1 (en) | 2006-05-31 |
| CA2427991C (en) | 2008-01-22 |
| WO2002036168A1 (en) | 2002-05-10 |
| TWI290471B (en) | 2007-12-01 |
| CA2427991A1 (en) | 2003-05-05 |
| AU2002211018B2 (en) | 2004-08-05 |
| DE60120211D1 (en) | 2006-07-06 |
| ATE327770T1 (en) | 2006-06-15 |
| AU1101802A (en) | 2002-05-15 |
| JPWO2002036168A1 (en) | 2004-03-18 |
| DE60120211T2 (en) | 2007-04-12 |
| JP4062436B2 (en) | 2008-03-19 |
| US20040043964A1 (en) | 2004-03-04 |
| BR0115058A (en) | 2003-10-28 |
| KR20030051773A (en) | 2003-06-25 |
| EP1338288A1 (en) | 2003-08-27 |
| KR100526285B1 (en) | 2005-11-08 |
| EP1338288A4 (en) | 2004-12-29 |
| CN1473054A (en) | 2004-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1222318C (en) | Cellulosic particle for pharmaceutical preparation | |
| CN1296387C (en) | Cellulose powder | |
| EP2161036B1 (en) | Cellulose fine core particle, and method for production thereof | |
| CN1202815C (en) | Sustained-release dosage form containing tramadol saccharin salt | |
| CN1223341C (en) | Spheroids, methods for their preparation and pharmaceutical compositions | |
| CN1926175A (en) | Porous cellulose aggregate and composite shaped article comprising such aggregate | |
| CN101031285A (en) | Compositions containing microparticles and methods for their preparation | |
| CN1489455A (en) | Delayed Release Drug Formulations | |
| CN1684665A (en) | Solid pharmaceutical formulation comprising telmisartan | |
| CN1798796A (en) | Cellulose powder | |
| EP2554169A1 (en) | Pharmaceutical preparation comprising phenylalanine derivative | |
| CN1662237A (en) | Controlled-release drug composition | |
| CN1301104C (en) | Sustained release preparations and process for producing the same | |
| EP3815680A1 (en) | Processing method for raw drug particles of non-uniform particle size | |
| CN1161106C (en) | Pharmaceutical composition with improved taste | |
| CN1794993A (en) | Pharmaceutical composition containing benidipine hydrochloride | |
| CN1713896A (en) | Spheroids, preparation method thereof and pharmaceutical compositions | |
| JP5503192B2 (en) | Method for producing bioactive substance-containing particles | |
| CN1612873A (en) | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical composition containing the compound | |
| CN101032479A (en) | Medicine for treating gastrointestinal ulceration and its preparing process | |
| CN101340896A (en) | Compressed solid dosage form containing low solubility drug and method for its preparation | |
| US20090048336A1 (en) | Escitalopram oxalate powders | |
| CN1856328A (en) | Compositions for orally rapidly disintegrating tablets | |
| CN1813728A (en) | Enteric controlled release film coated omeprazol zinc oral solid formulation, oral semi-solid formulation and its preparing method | |
| CN109419778B (en) | A kind of rivaroxaban tablet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051012 Termination date: 20151106 |
|
| EXPY | Termination of patent right or utility model |